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The importance of residual renal function (KRU), as effective renal
clearance (KRE) for the adjustment of KT/V. NB. Pinho, MG. Lima, L.C.
Pereira, RB. Mendes, H.P. Athaide, and J. Oliveira, Grupo de Assistência
Médica Nefrologica LTDA, Gamen, Brazil. The objective of this study was
to demonstrate the importance of the residual renal function in the KT/V
adjustment of patients on hemodialysis (HD): 185 renal chronic patients
(RC) were evaluated in a regular dialysis program by means of urea
kinetic modeling making a total of 376 carried out from 11/89 to 4/93.
Residual functions with urinary volume more than 400 ml (collected in the
interdialitic interval) were evaluated. All the patients evaluated were in
the hemodialysis program three times a week. The following formulae
were used to calculate the KRE, KRU, KT/V and KT.
KRU
Vu(ml) X Uu(mg/dl)
time(min) x (0.25 X urea post-2nd RD + 0.75 X urea pre 3rd HI) of the week)
KRE = 5.9 x KRU
urea pre-HDicriv = Log
nep urea post-HI)
KT = k+ 3v + KJ&E
Results obtained: There were 185 patients evaluated (88 patients with
residual renal function). KRU (mean) was 2.01 2.51; KRE (mean) was
0.34 0.43; KT/V (mean) was 0.86 0.34; KT (mean) was 1.21 0.53;
mean per (protein catabolic rate) was 0.95 0.33. Twenty-six patients
recovered part of their renal function after the beginning of the HD; they
also had severe arterial hypertension (SAH) KRE (mean) at the beginning
of HD treatment. KRE (mean) at the beginning of RD treatment was 0.29
0.17, and KRE (mean) after beginning of HD treatment was 0.48
0.69. Results of the analysis: About 47% of the patients who were
evaluated showed residual renal function which corresponded to 28% of
the average KT at the center. The average KT of the center was within the
"ideal" limit recommended by the literature (KT = or more than 1.2),
Among 88 patients with residual renal function, 26 recovered part of their
renal function, increasing the average KRE to 39.6% of their dialitic
necessities. These patients had SAH as a basic disease and as they got
better, their renal function was partly recovered. The mortality rate
related to uremic complications considering the HD adjustment by means
of urea kinetics was the following: 1 death caused by digestive hemorrhage
and 2 deaths caused by sepsis (diabetic patients). For the KT/V adjust-
ment, the per was also evaluated. Patients who had per greater than 1.2
had their KT/V adjusted to similar values. Conclusion: KRU must be
evaluated for the KT/V adjustment. Forty-seven percent of the patients
evaluated had KRE = 28% of their dialitic necessities for the ideal KT/V.
Patients with SAil should be evaluated more frequently.
Prolonged beta adrenergic stimulation—A new way to reduce serum
potassium concentration in hemodialysis. MC.M Castro, IF. Freitas Jr.,
M. Marcondes, and E. Sabbaga, Department of Nephrology, University of São
Paulo School of Medicine, São Paulo, Brazil. Hyperkalemia is a common
cause of death in patients undergoing hemodialysis (HD). On the other
hand, acute beta adrenergic stimulation is a fast, safe and effective way to
reduce serum potassium concentration (Ks) in patients on HD. The aim of
this study was to evaluate the efficacy and safety of prolonged beta
adrenergic stimulation on the homeostasis of Ks. We studied 12 patients
without any residual renal function, and who were not receiving beta
blockers or angiotensin converting enzyme inhibitors. HD was performed
three times weekly and each patient was observed during three weeks. In
the first one, before each HD, a blood sample was obtained for Ks levels.
Alter this the patient received salbutamol 2 mg, twice a day, for 14 days.
Once again in the third week, before each HD, a blood sample was
obtained for Ks levels. Three patients (25%) refused to continue the trial
because they developed symptoms of palpitation and tremor. The table
presents the Ks levels and the systolic, diastolic and mean arterial pressure
in the first and third week in 9 patients who completed the trial (X Sn).
Week Ks SBP DBP MAP
1 5.04 0.48 141 27 87 11 107 14
3 4.44 0.54 141 29 86 15 105 18
P <0.05 NS NS NS
We concluded that prolonged beta adrenergic stimulation can be used as
an alternative way to reduce Ks levels in patients with chronic renal failure
on HD. This effect is not accompanied by alteration in the blood pressure;
however, some patients present side effects which require the interruption
of the drug.
Ultrafiltration and buffer influences on left ventricular performance
changes induced by hemodialysis. L.C. Martin, IC. Velasco, P. Barretti, K
Okoshi P.J.F. Tucc4 and R.J.S. Franco, Dept. of Medicine-FMB-UNESP-
Botucatu, São Paulo, Brazil. Ejection fraction (EF) and end systolic
meridional stress (ESMS) were evaluated by echocardiography and con-
comitant sphygmomanometry pre- and 45 minutes post-hemodialysis
(HD) in 23 HD patients who were without primary cardiopathy. HD
protocol was done as follow: acetate + UF (AcUt); bicarbonate + UF
(BicUf) and bicarbonate isovolemic (Biclso). Results were (mean SD):
AcUf BicUf Biclso
Pre Post Pre Post Pre Post
BP mm 163 32 142 30 156 33 127 25 156 33 164 36
Hg 96 24 86 22 93 25 74 18 92 20 96 17
Weightg 64 7 60 8 57 11 54 a 55 12 55 12
EF% 66±4 65±5 73±7 70±9 69±6 72±8
ESMS 62 8 44 12 54 18 40 12 53 25 53 20
g/cm2
a P < 0.05 compared with Pre
RD AcUf or BicUf induced a decrease in ESMS with no expected increase
in EF. Biclso did not produce any change. These preliminary data suggest
that the change in LV performance produced by HD was not due to an
intrinsic effect of the buffer, but rather was induced by ultrafiltration.
S. aureus chronic nasal carriage in CAPD patients: A molecular
epidemiology study. D. Barbosa, H. Ajzen, M Cendoroglo, S. Draibe, H.
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Sader, R. Sesso, N. Schor, and A. Pignatan, Escola Paulista de Medicina
(EPM), São Paulo, Brazil, and Universily of Iowa, Iowa City, Iowa, USA.
CAPD patients who are S. aureus (Sa) chronic nasal carriers are at high
risk to develop peritonitis. The overall incidence of peritonitis in CAPD
patients at EPM is 1 episode/9 months of treatment, in which Sa account
for 40—44% of all episodes. To study the perseverance of Sa nasal
colonization, we studied 16 CAPD patients who were characterized as
nasal carriers from 1987—1988. Twelve out of these 16 patients remained
nasal carriers over a period of 4 years. Thirty-three Sa isolates were
submitted to chromosomal DNA analysis by pulsed-field gel electrophore-
sis after digestion with the restriction endonuclease Smal. In 5 patients we
detected the same strain colonizing the nares up to 4 years of follow-up.
Two patients revealed the same nasal and peritoneal strain, confirming the
relationship between Sa chronic nasal state and development of peritoni-
tis. Moreover, the strains from these two patients presented the same
DNA profile, suggesting the possibility of cross-transmission among
(CAPD) patients.
Nutrition and adequacy of dialysis evaluation in CAPD patients. E.
Homsi, 0. Marson, G. Alves, M. Amar, M.I. Salati, P. V. Bottini, P.R.
Caivaiho, and C. Stabile, Clinica de Nefrologia Santa Rita, São Paulo,
Brazil. Nutrition and adequacy of dialysis were evaluated in 31 CAPD
patients. They were in CAPD program for more than 3 months, (mean
19.2 16 months), with 4 changes of 2 liters per day. We studied global
weekly Kt/V of urea, total creatinine clearance and residual renal creati-
nine clearance, anthropometric measures, protein catabolic rate (PCR),
serum albumin, 24 hour proteinuria and albumin, and protein content of
the 24 hour dialysate. Nutritional surveys of 3 days were performed in 16
patients. Weekly Kt/V was between 1.4 and 3.7 (mean 2.3 0.5). In 7
patients (22.5%) the Kt/V was under 1.8. On the other hand, total
creatinine clearance was over 50 liters/week, between 51.2 and 158.9
literlw (mean 75.5 22.7 liter/week/1.73 m2). PCR was between 0.73 and
1.76 (mean 1.18 glday/kg body weight). Protein intake was between 0.57
and 1.6 (mean 1.08 g/kg body weight/day). There was a correlation
between Kt/V and total creatinine clearance (r = 0.58, P < 0.01), Kt/V and
renal residual clearance (r = 0.4, P < 0.05), total creatinine clearance and
renal residual clearance (r = 0.87, P < 0.001), Kt/V and PCR (r = 0.57, P
< 0.01) and Kt/V and body surface area (r =
—0.53, P < 0.01). Serum
albumin ranged from 2.7 to 4.3 (mean 3.5 0.4 g/dl). Serum albumin did
not correlate with Kt/V, PCR, protein intake or protein loss in the
dialysate or urine. Protein and albumin losses in the dialysate were,
respectively, 12.3 3.9 glday and 5.9 3.4 glday. Mean 24 hour
proteinuria was 0.67 0.8 g/day. Protein losses may decrease serum
albumin plasma levels and impair its correlation with protein intake or
dialysis quality. In conclusion, in 22.5% of the patients in a conventional
CAPD program, the dialysis was not adequate, particularly in patients with
low renal residual clearances and high body surface area. Serum albumin
did not mirror the nutritional state of the studied patients.
Effect of L-arginine (L-ARG) on renal function and blood pressure
(HP) in essential hypertensives on low and high salt diets. C. Amodeo, V.
Dichtchekenian, E.A. Santos, and J.C. Heimann, Nephrology Section, Fac-
ulty of Medicine, University of São Paulo, São Paulo, Brazil. Objective:
Animal studies have shown that the L-ARO/NO pathway function is
decreased on salt overload in Dahl-S compared to Dahl-R rats. The
following study was performed in order to verify if a similar disturbance is
present in salt sensitive human hypertensives. Methods: Eight essential
hypertensives (diastolic BP between 90 and 115 mm Hg, 8 women, 3
blacks, mean age 44 years, range 30—59) were sequentially submitted to a
low (LSD = 45 mEq Na/day, 7 days) and to a high (HSD = LSD + 12 g
NaC1/day, 7 days) salt diet after 8 weeks on placebo only. On day 5 and 6
of each diet, 24 hour urine collections were obtained for Na, K, and
creatinine (Cr) determinations. In the morning of the 7th day on LSD and
HSD, L-ARG (20 g in 200 ml of 5% glucose, 30 mm) was administered to
the patients. Mean blood pressure (MBP), urine collection, and blood
samples were obtained hourly from 2 hours before until 2 hours after the
beginning of L-ARG infusion. Salt sensitivity (SENS) was considered as
the percent change of MBP from the 7th day on LSD to the 7th day on
HSD. Results (mean SD): The L-ARG effects are given in the table
below. Before (B) and after (A) L-ARG infusion; p-A vs. B.
LSD HSD
B A P B A P
GFR mI/mm 133 23 118 28 NS 124 26 120 37 NS
UNaV mEq 7 7 15 12 <0.05 17 10 24 8 <0.05
MBP mm Hg 121 8 110 9 <0.05 127 9 114 7 <0.05
On HSD, SENS correlated with the GFR decrease induced by L-ARG (r
= 0.83, P < 0.05). Conclusions: The increase with SENS of the L-ARG
effects on GFR on HSD may indicate that the patients with the highest
SENS have a decreased L-ARG/NO system function.
Bradykinin inhibition induces insulin resistance and increases blood
pressure during hyperinsulinemia. 0. Kohlmann, FAR. Neves, M. Gi-
noza, ML. Cezaretti A. Tavares, A.B. Ribeiro, I. Gavras, and H. Gavras,
Nephrology Division, Escola Paulista de Medicina, São Paulo, Brazil, and
Boston University, Boston, Massachusetts, USA. Objective: To evaluate
bradykinin (BK), nitric oxide (NO) and prostaglandin (PG) participation
in the glucose uptake (GLU-UPT) and blood pressure (BP) response to
hyperinsulinemia in normotensive rats. Methods: Four groups of rats were
prepared for GLU-UPT (mg/kg/mm) and BP (mean change, mm Hg)
determinations during a euglycemic insulin clamp (insulin infusion rate: 6
mU/kg/mm for 120 mm) as follows: (1) Group C, N = 7: untreated control
rats; (2) Group BKI, N = 6: rats treated with a specific BK receptor
antagonist, LG-7: 200 .sg/kgfminJi.a. for 130 mm; (3) Group L-Name, N =
6: rats treated with the NO synthase inhibitor L-Name, 200 g/kg/min for
120 minutes; and (4) Group INDO, N = 7: rats treated with indomethacin
(2 mg/kg/day/s.c.) for 7 days before study. Results (mean SD):
C BKI L-Name INDO
Glu-UPT 20.8 2.4 6.6 4.8a 20.2 4.5 20.0 3.5
BP 2±7 22±ltr 43±lla 12±5a
a P < 0.05 vs. remainders
Conclusion: BK but not PG or NO inhibition induces insulin resistance,
whereas all 3 vasodilators, especially BK and NO, act as counterbalance
for the hypertensive effects of hyperinsulinemia in normotensive Wistar
rats.
Enhanced glucose metabolism, increased insulin sensitivity, and higher
blood pressure during chronic salt overload in Wistar rats. N.KC. Lima,
E.A. Santos, MM Okamoto, D.H. Matsushita, F.B. Lima, N.S. Hell, R.R. de
Souza, D.MC. Sequeira, MJ. Oliveira, V.J. Oliveira, W. Campestre, andJ.C.
Heimann, Nephrology Section, Faculty of Medicine, Endocrinology and
Metabolism Laboratoiy of the Physiology and Biophysics Department, and
Department of Anatomy of the Institute of Biomedical Sciences, University of
São Paulo, São Paulo, BraziL In order to study the effect of chronic oral
salt overload, male Wistar rats received from weanning a low (LSD, 0.15%
NaC1, N = 6) or a high salt diet (HSD, 7.92% NaCI, N = 6). Blood
pressure (BP, tail cuff), body weight (BW), 24 hour sodium (UNaV) and
potassium (UKV) excretion, creatinine clearance (Ce,), right kidney mass(KM), left ventricular mass (LVM), intravenous GiT with insulin deter-
minations, glucose metabolism and insulin sensitivity in isolated adipo-
cytes were measured between the 12th and 15th weeks of age. Results
(mean SD): BP and KM were higher on HSD than on LSD (BP: 145
11 vs. 115 5mm Hg,P = 0.00008; KM: 4.4 0.4vs. 3.1 0.2 mglg Body
W, P = 0.00002). No significant BW and LVM differences were observed
between HSD and LSD (BW: 383 25 on LSD vs. 362 20 g on HSD,
P = 0.14). UNaV, UKV and Ccr were higher in HSD (P < 0.05). Fasting
glucose (GLU) and plasma insulin levels (INS) were lower on HSD than
on LSD (GLU: 84 5 on HSD vs. 102 4 mg/dl on LSD, P =0.00003;
INS: 13 5 on HSD vs. 22 7 lU/mi on LSD, P =0.02). In adipocytes,
3H-2 deoxiglucose uptake (UP), 14C-glucose oxidation (OXID) and
'4C-glucose incorporation in lipids (INCORP) are shown in the table
below.
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UP UP INCORP INCORP OXJD OXID
basal max. basal max. basal max.
pMol/cm2 nMol/105 cell/hr nMol/105 cell/hr
LSD 2,1 0.6 6.1 1.7 7.7 2.3 10.5 4.1 3.1 1.1 4.7 1.8
HSD 5.1 1.0 12.3 1.1 14.3 2.7 20.7 4.1 10.9 2.5 14.8 3.2
P <0.0001 =0.00001 =0.0011 =0.0015 <0.0001 <0.0001
Plasma insulin levels at half of the maximal UP (EC5O) were not
significantly different between HSD and LSD. Insulin receptor density was
higher during HSD (HSD: 8.1 2.4 vs. LSD: 3.5 1.8/m2, P 0.004).
In conclusion, salt overload stimulated glucose metabolism and increased
BP and KW. Higher insulin sensitivity was also observed in association
with prolonged high salt ingestion.
High salt diet suppresses sympathetic nerve activity In salt-resistant
hypertensives. S.B. Abrahão, 7'. Tinucci, M. Marcondes, and D. Mion Jr.,
Hypertension Uni4 Nephrology Division, University of São Paulo, São Paulo,
BraziL Salt-resistant hypertensives show reduction in plasma norepineph-
rine on a high salt diet but it is not known whether the sympathetic nerve
activity is suppressed. To test this hypothesis 6 salt-resistant (mean blood
pressure increases < 10% when they were changed from a low to a high
salt diet) hypertensives (6 women, 1 black, age = 41 9 years) received
a low and a high salt diet (30 and 300 mEq/day, 7 days each) in a random
order. On day 7 of each diet the sympathetic nerve activity was recorded
by microneurography. The 24-hour sodium urinary excretion, body weight
and mean blood pressure on day 7 of the high and low salt diets were,
respectively: 173 64 versus 10 6 mmol/day (P< 0.05), 59 10 versus
58 10kg (F> 0.05), and 103 9 versus 103 6mm Hg (P> 0.05). The
sympathetic nerve activity was significantly lower on day 7 of the high salt
diet than on day 7 of the low salt diet (18 6 vs. 37 11 bursts/minute,
P < 0.05). The data confirm through direct recordings that the sympa-
thetic nerve activity is suppressed in salt-resistant hypertensives on high
salt diet and suggest that this suppression is one of the mechanisms related
to the lack of blood pressure increase.
Methylpredinosolone (ME) induced hypertension (LIT) in rats: A role
for diminished insulin sensitivity (IS). M.D.A. Lima, M Ginoza, A.
Tavares, D. Dufloth, L. Michelin, A. Ribeiro, and 0. Kohlmann Jr.,
Nephrology Division, Escola Paulista de Medicina and Physiology-Biophisics
Department, ICB-USP, São Paulo, Brazil. To determine the importance of
the IS in glucocorticoid induced HT, we administered ME 5 mg/kg/week!
to Wistar rats that were either trained on the treadmill for 13 consecutive
weeks (group ME-T, N = 22) or kept sedentary (group ME, N = 27). As
controls, normotensive rats trained (C-T, N = 18) or untrained (C, N =
20) were used. Tail arterial pressure (TAP) was measured weekly. At the
13th week fasting plasma glucose (Glu) and insulin (Ins) levels and
glucose uptake (Glu-UPT) during an euglicemic clamp were determined
in all groups. Blood pressure response sympathetic nervous system
blockade (BP-SNS), plasma norepinephrine (NE) and epinephrine (E)
levels and the left ventricular weight (LVW) were also determined.
Results (mean SD):
Groups ME ME-T C-T C
TAP mm Hg 148±7" 133± 13 127 121± 5
Glu mg% 92 17" 96 17 83 16 77 9
Ins mU/liter 13 3 14 3 9 2 7 1
Glu-UPT mg/kg• mm
BP-SNSmmHg
NEng/ml
E ng/ml
LVW g/lOO g body wt
8.1 l.4t)
1958l""
241 44""
2.6 0,1ab
11.7 1.2
—9±7
50±32
117 55
2.3 0.2
15.7 0.8
—14±11
88±53
126 53
2.4 0.2"
16.7 1.1
—11±11
116± 38
157 33
2.0 0.1
P < 0.05 a group C; "vs. group ME-T
Training was associated with improvement in IS and reduction in BP and
SNS activity in ME-hypertensive rats. Conclusion: Insulin resistance
appears to play a pivotal role in ME-induced HT and its improvement is
associated with amelioration of HT.
Renal hemodynamic evaluation in diabetic rats with predisposition to
hypertension: Effects of cilazapriL MV.A. Perez, M Ginosa, M.D.A, Lima,
A.B. Ribeim, and 0. Kohlmann Jr., Nephrology Division, Escola Paulista de
Medicina, São Paulo, BraziL Hypertension is frequently associated with
diabetes mellitus (DM) and enhances the development of diabetic ne-
phropathy, in which glomerular hyperfiltration is one of the most promi-
nent features at its early stages. In this study, we evaluated renal function
of animals predisposed to hypertension (borderline hypertensive rats,
BHR) with (BHR + DM, N = 8) or without (BHR, N = 8) DM induced
by streptozotocin 50 mg/kg. Diabetic Wistar Kyoto rats (WKY + DM, N
= 7) or non-diabetic rats (WKY, N = 7) were used as controls. In 2
additional groups, the ACE inhibitor, cilazapril (CIL, 10 mg/kg/day) was
administered to diabetic BHR (BHR + DM + CIL, N = 8) and to
non-diabetic BHR (BHR + CIL, N = 9).All animals were followed by 12
weeks and had tail arterial pressure (TAP, mm Hg) monitored weekly. At
the end of the 12th week, glomerular filtration rate (GFR, mI/mm), renal
plasma flow (RPF, mi/mm), and filtration fration (FF, %) were evaluated
by inulin and paraaminohippurate clearances in awake animals. Results
(mean SEM):
BHR
BHR+
CIL
BHR+
DM
TAP basal 133 2 137 2 138 3C
TAP 12th 159 3 112 3 173 8
GFR 0.65 0.05 0.61 0.07 1.04 0.1"
RPF 2.91 0.33 2.22 0.21 4.17 03"
FF % 23.9 2.17 27.66 2.3 24.5 1.3
BHR+DM
+CIL WK
WK+
DM
TAP basal 136 3 113 2 115 2C
TAP 12th 125 5" 128 3 150 3C
GFR 0.73 0.05" 0.72 0.09 0.90 0.08
RPF 2.34 0.18" 2.54 0.3 2.84 0.3
FF % 32.15 2.5 29.0 1.9 31.2 0.77
a P< 0.05 vs. BHR, "P < 0.05 vs. BHR + DM; cp < 0.05 vs. baseline
Conclusion: DM in animals predisposed to hypertension enhances the
hypertensive state, induces glomerular hypertension, and increases renal
plasma flow. Cilazapril corrects these abnormalities.
Renal lithiasis treatment and bone densitometry. J.A. Meneses, P.R
Alves, MAM. Drummond, P.C,G. Guerra, P.P. Ragg, MA Fonseca, and
G.M. Dias, Lithocentm, Centro de Tratamento de Cálculos Renal e Biliar
M.L.D, Belo Hori2onte, BraziL One hundred and sixty patients, whose ages
ranged from 6 to 59 years old (average 36.02 4.5 years) were followed.
There were 57% men, 72% white, and all of them had nephrolithiasis with
hypercalciuria. Forty percent had renal hypercalciuria, 7.6% had absorp-
tive hypercalciuria type 1, 28.8% had absorptive hypercalciuria type II, and
23% had undetermined hypercalciuria. All of the patients underwent
lumbar spine bone mineral densitometry (BMD) and proximal femural
densitometry with a dual emission photon device with X-ray, connected to
a computer where all the data were analyzed. The results showed that
BMD done before the treatment of the renal hypercalciuria group was
statistically lower than BMD of absorptive hypercalciuria type II group
(1,029 0.03 g/cm x 1,302 0.08 g/cm; P < 0.05). After a year of
treatment with potassium citrate and thiazides, we observed a significant
recovery of BMD, especially in renal hypercalciuria and undetermined
hypercalciuria groups. The difference between the groups disappeared
after a year of treatment.
Multicentric study of nephrolithiasis In Brazil (MIJLTILIT). Multilit
group (presented by C.G. Novoa), Nephrology Division, Escola Paulista de
Medicina, São Paulo, BraziL We present data from 451 lithiasis patients
(mean age 39 13 years, 78% white, 13% mulattos, 7% blacks and 2%
Orientals) with similar distribution among the sexes. The table below
shows the number and percentage of isolated or associated metabolic
diagnosis from 11 centers distributed among 7 states of Brazil (in all
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centers, except in Bahia, the oral calcium load test was performed).
Numbers in parentheses are percents.
State N RH AH UH
Bahia (BA) 7 0 0 0
M. Gerais (MG) 133 18 (14) 6 (5) 7 (5)
Pernanbuco (PE) 24 2 (8) 0 1(4)
Parana (PR) 12 1 (8) 0 0
Rio Janeiro (RJ) 54 5 (8) 1(2) 3 (6)
Rio G Sul (RS) 40 2 (5) 2 (5) 1(3)
São Paulo (SP) 181 22(12) 16 (9) 7 (4)
State sCa , sP UAHE UTI
MD
not found
Bahia 0 1 (14) 5 (71) 0 1(14)
M. Gerais 17 (13) 6 (4) 28 (21) 2(2) 51(38)
Pernanbuco 4 (17) 4(17) 11(46) 0 9 (37)
Parana 2(16) 0 0 0 7(58)
Rio Janeiro 2 (4) 4 (7) 9 (17) 3 (6) 21(39)
Rio GSul 5(13) 2(5) 9(23) 0 19(47)
São Paulo 26 (14) 17 (9) 61(34) 1(0.6) 64(35)
Abbreviations are: RH, renal hypercalciuria; AH, absorptive hypercal-
ciuria; UH, undetermined hypercalciuria; sCa, serum calcium; sP, serum
phosphate; UAHE, uric acid hyperexcretion; UTI, urinary tract infection;
MD not found, metabolic disturbance not found
Considering data from all states, the metabolic disorder most frequently
found was UAHE, presented by 27% of patients, followed by hypercalci-
uria (either RH, AH or UH) by 21% of the patients. Hypercalcemia was
presented in 12%, hypophosphatemia in 7% and UTI in 2% of the
patients. From centers which perform determination of urinary citrate,
hypocitraturia was identified in SP in 9/72 (12%) of the assessed patients,
36/91 (39%) in MG and not in any patients from RJ and PE. Regarding
centers that assess oxalate determination, hyperoxaluria was observed in
34% (9/55) of the patients in MG, 25% (1/4) in PE and 8% (1/13) in RS.
Primary hyperparathyroidism was found in 2 patients from MG and 2 in
SP. UAHE was observed in 5% and marginal hypercalciuria in 1% of all
patients from several states. Metabolic disturbance was not observed in
172/451 (38%) of the patients.
Brazilian multicientric study of pediatric lithiasis (Multiped). Cooper-
ative Group of Nephrologic Centers presented by D.C. Thomé and F Schor,
Pediatrics Department of the Brazilian Society of Nephrology, São Paulo,
Brazil. In order to evaluate the characteristics of lithiasis among the
population of Brazilian children, a cooperative study has been organized,
unifying the work of 13 medical centers in several states of Brazil. At the
present phase we have tried to characterize some clinical aspects of this
pathology. Presently, only 6 medical centers have answered our invitation
to participate, and we have studied 247 children, of whom 158 (64%) are
male and 89 (36%) are female. The age at which the settlement of the
disease was detected ranges from 3 months to 17 years. Only 3% of this
population was asymptomatic. The initial prevailing symptoms were:
hematuria, 78 patients (28.9%); abdominal and/or lumbar pain, 63
(23.4%); hematuria associated with pain, 50 (18.5%), and only 28 (10.4%)
with nephritic spasm (colic ?) in association with hematuria. Some
frequent symptoms were dysury, 21 (7.8%); recurring infection of the
urinary tract, 15 (5.5%); elimination of calculi, 3 (1.1%), and others,
(1.3%). Nephritic malformations were found in a small group of patients
(9/247): falciform kidney (2); crossed nephritic ectopy (2); stenosis of
pleurourethral junction (3); one kidney (2).
Potassium intake in stone forming patients (SF). L.A. Martini, I.P.
Heilberg, L. Cuppari and N. Schor, Nephrology Division, Escola Paulista de
Medicina, São Paulo, Brazil. A low potassium intake has been related with
stone formation, probably due to an increased calcium excretion, or a
reduced citrate excretion, which in normal subjects is induced by potas-
sium deprivation. In order to evaluate the potassium intake of stone
formers, 3 days of dietary records were obtained from 86 patients, 50% of
whom had associated hypocitraturia. The mean potassium intake was 55
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20 mEq/day. To further assess the correlation between potassium intake
and calciuria and citraturia, 24 hour urine was collected. The mean
calcium excretion was 228 124 mg/day, and citrate was 437 237
mg/day. No significant correlation was observed between potassium intake
and either calcium or citrate excretion. For instance, in hypocitraturic
patients (N = 43), a weak but positive correlation was observed (r = 0.31;
P < 0.05). Despite consumption of foods rich in potassium, usually
observed among these patients, such as tomatoes, oranges, bananas, and
coffee, the total amount was not enough to reach the proposed RDA
requirement. The results suggest that a low potassium intake may at least
in part contribute to decreased urinary citrate excretion in stone forming
patients.
Renal scan with DTPA and DMSA in lithiasis patients with unilateral
obstruction. L. Gandoipho, M.C. Monteiro, I.P. Heilberg, H. Ajzen, and N.
Schor, Division of Nephrology, Escola Paulista de Medicina, São Paulo,
Brazil. To evaluate functional alterations due to obstructive factors, 21
patients (17F/4M) with renal unilateral calculi and hydronephrosis were
submitted to renal scan with DMSA and DTPA. All patients showed
normal renal function (mean age 42 10 years) and estimated time of
hydronephrosis was between 1 and 48 months. Evaluation through DMSA
showed the presence of scarring in 17/21 (81%). We observed a percentual
reduction of function in the affected kidney in 12/17 (70%) which was
associated with the presence of scarring (P < 0.05). History of recurrent
urinary tract infection (rUTI) was referred to in 8/17 (47%) and previous
surgery in 3/17 (18%) of the patients. The evaluation through DTPA
showed a percentual reduction of the function of the affected kidney in
14/21 (67%). From these patients, 13 showed injury of renal pelvis, and 9
of them were associated with injury of the renal cortex. The association
between functional alteration and cortical damage was significant (P <
0.05). Results of DMSA suggest that permanence of obstructive calculi for
a long period of time may lead to important parenchymal damage
resulting in scarring, irrespective of associated rUTI and/or previous
surgery. The results of DTPA suggest important damage in the renal pelvis
in 93% of the patients, indicating that early intervention should reverse
the consequences of imposed injuries on the affected kidney.
Test of urinary acidification in lithiasis patients with bypocitraturia.
R.O. Patino, I.P. Heilberg, S. Laranja, H. Ajzen, and N. Schor, Nephrology
Division, Escola Paulista de Medicina, São Paulo, Brazil. The hypocitraturia
observed in lithiasis patients may be related to the presence of alteration
in urinary acidification. In a previous study, we had evaluated 59 hypoci-
traturic patients, 44% of whom revealed a fasting urinary pH higher than
5.5. The aim of the present study was to further test this hypothesis in a
larger number of patients. Among 165 patients with hypocitraturia, 30
(18%) presented a urinary pH higher than 5.5. From these 30, 15 were
submitted to an oral acid load administered as NH4CI (100 mg/kg). The
control group included 10 healthy subjects. The results of urinary param-
eters before (Pre) and after (Post) the acid load are shown as X SE.
pH
Pre Post
T
p.Eq
Pre
A
/min
Post
NH4
p.Eq/min
Pre Post
HCO3
mEq/liter
Pre Post
Control 6.3
0.1
10.9
1.4
38.8
2.5
28.3 51.5
3.2 3.5
— —
— —
Hypocitraturia 6.4
0.1
5.4
0.2
8.6
1.0
22.5
2.2
21.9 48.1
3.0 5.0
4.8 2.1
0.8 0.2
Abbreviations are: TA, titratable acidity; NH4, ammonium excretion;
HCO3, bicarbonate.
Mean values were not significantly different between groups. However,
4/15 patients presented a pH higher than 5.5 after NH4CI. One of them, in
spite of not having a lower pH value, presented enhanced TA and NH4
after acid load. The results obtained suggest that the mechanisms of
urinary acidification are preserved in the majority of the hypocitraturia
patients.
Acute and chronic effects of FK 506 (FK) on glomerular hemodynamics.
E.R.M. Souza, MA. Boim, C. Bergamaschi, H. Ajzen, JO. Pestana, C.
Versolato, and N. Schor, Nephrology Division, Escola Paulista de Medicina,
São Paulo, Brazil. To evaluate FKSO6 nephrotoxicity, 3 groups of MW rats
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were studied: acute studies (N = 9), before and after FK (3 mg/kg BW, i.v.,
in bolus), and chronic studies: vehicle (N = 8, cremophor + isopropyl
alcohol, 10 days, i.p.) and FK (N = 8, 0.6 mg/BW, i.p., 10 days).
OFR SNOFR QA
Acute
before
after
Chronic
Vehicle
p1ç
0.74 0.03
0.32a 0.07
0.97 0.02
0756÷004
43 6
2& 3
38 3
296÷2
133 21
100 13
118 10
73b÷6
P0 RT 'Cf
Acute
before
after
Chronic
Vehicle
FK
42 1
41 1
42 1
43 1
3.5 0.8
4.0 0.7
3.0 0.2
516 0.5
0.101 0.023
0.079 0.013
0.148 0.011
00876 0.011
Results are X SE: P < 0.05 vs. a before; chronic EK vs. 6vehicle
After the acute infusion, total OFR (mI/mm) and single nephron (SN)
OFR (nI/mm) declined by 55% and 40%, respectively, due to reduction of
25% in glomerular plasma flow rate (QA, nl/min) and 20% in ultrafiltra-
tion coefficient (Ks, nl/s mm Hg). No effect of FK on mean glomerular
hydraulic pressure mm Hg) was observed, but a slight increase(15%) on the total arteriolar resistance (RT, i0 dyn s cm5) was
observed. In the chronic FK group, the reduction on OFR (20%) and
SNOFR (25%) was less impressive. The reduction in °A (40%) and on K1
(40%) was more striking due to an increase of RT (70%). Thus, both acute
and chronic treatments similarly affect renal function, mainly by modifying
QA and 'Cf.
Effect of hypercholesterolemia (ftC) on renal phosphate (Pi) transport.
f. Castro, J.L. Monteiro, and A.C. Seguro, LaboratOrio Pesquisa Básica,
Nefrologia, São Paulo, Brazil. Recent studies have demonstrated that
chronic HC decreases glomerular filtration rate, but direct tubular effects
have not been described. The effect of HC on renal function was studied
in normal rats and in animals maintained on a high cholesterol diet (1%
cholic acid, 4% cholesterol) for 2 weeks. Plasma cholesterol was 64 2
and 169 21 mg/dl, respectively. The creatinine clearance was similar in
both groups; however, early tubular effects were observed. In HC-rats the
urinary volume was 20.4 2.3 mI/day, significantly greater than in normals
13.5 2.3 mI/day (P C 0.01), which was accompanied by an increase in
absolute urinary phosphate excretion (338.0 53.9 vs. 580.5 45.6 aM/24
hr, P C 0.03). The mechanism of this phosphaturic effect of HC was
studied in vitro, by the method of 32Pi uptake of renal brush border
membrane vesicles (BBMV) of the proximal tubules from rats with high
and normal cholesterol diets. Transport was measured with gradients of
inorganic phosphate (80—1280 gM). Compared to controls, phosphate
transport in BBMV from HC-rats had a similar Vms,, (2177 vs. 2492
pM/mg prot, 20 see) and a higher apparent Km (696 vs. 549 jtM, P C 0.01).
These results suggest that HC induces a decrease of Pi proximal reabsorp-
tion by a reduction in the affinity of the transport system to phosphate in
these conditions.
Hydrochlorothlazide (HCT) enhanced water absorption in diabetes
lnsipidus (DI). AL Magaldi, KR. Cesar, and Y. Yano, Laboratorio de
Pesquisa Básica, Nephrology, São Paulo University, São Paulo, BraziL The
effect of HCT was studied in water and urea absorption in isolated
microperfused IMCD from Brattleboro and normal rats. Osmotic water
permeability (N x io cm/atm s), diffusional water permeability (row X
io— cm/s) and urea permeability (Pu X i0 cm/s) were determined. All
tubules were perfused and bathed with isotonic Ringer/HCO3 at 37°C with
pH 7.4. In normal rats, in absence of ADH the Pf rose from 2.4 0.7 to
8,1 1.1 (P C 0.01) after 10—6 M HCT and recovered to 3.9 1.1.
was 38.1 4.5 in the control period, 52.3 2.2 (P C 0.01) after HCT, and
37.7 6.2 in the recovery period. In Brattleboro rats the HCT enhanced
both Pf and D" HCT stimulated Pf decreased from 2.1 0.4 to 0.7
0.1 (P C 0.01) after adding iO M of prostaglandin £2 (POE2) and
recovered to 1.2 0.3 after withdrawal of POE2. Colchicine (Col)
(i0 M) decreased the Pf in tubules treated with HCT from 1.1 0.1 to
0.5 0.1 (P C 0.02). ADH (50 gU/mI) did not raise the Pf in the presence
of HCT (control 0.2 0.1; ADH 0.8 0.2, P C 0.05; ADH + HCT 0.7
0.1, NS) while in tubules treated only with ADH the Pf increased from
0.2 0.1 to 1.0 0.2 to 1.6 0.3. i0 si forskolin-stimulated Pf
increased from 0.8 0.2 to 1.1 0.2 (P C 0.02) after HCT. Urea
permeability was not modified by HCT. In summary, HCT: (1) enhanced
water absorption in absence of ADH; (2) was partially inhibited by POE2
and Col; (3) did not change urea absorption. In conclusion, the HCT
intrinsic effect of increasing water absorption in absence of ADH is
another mechanism by which HCT can reduce the DI polyuria.
Cl-dependent bicarbonate transport in renal cortical distal tubule of
the rat. R. Fernandez, and 0. Malnic, Departarnento de Fisiologia e
Biofisica, Instituto de Ciências Biornedicas, University of São Paulo, São
Paulo, BraziL Bicarbonate secretion in cortical collecting duct has been
attributed to an apical C1/HCO3 exchanger. It is also known that antidi-
uretic hormone (ADH) stimulates distal H secretion, possibly masking
bicarbonate secretion. Therefore, we compared distal acid-base transport
in homozygote Brattleboro (BRB) rats, deficient in ADH, and in Wistar
rats. Cortical distal tubules were perfused with 10 mM phosphate Ringer at
pH 6, and its alkalinization was measured with double resin pH/reference
microelectrodes. Control and alkalotic rats were used, the latter receiving
an infusion of NaHCO3 plus KHCO3 after 3—5 days drinking an alkaline
solution, leading to a blood pH of 7.57 0.013 (N = 15). During
stationary perfusion, control Wistar rats had a rate of alkalinization of 0.21
nmol/cm2 s in early distal (ED) segments, and 0.51 nmol cm2 - s in late
distal (LD) segments, but perfusion with zero Cl solutions (Cl substituted
by gluconate) did not change this rate. The same occurred in alkalotic
Wistar and control and ED of alkalutic BRB rats. However, in LD of
alkalotic BRB rats, stationary pH (pHs) was 7.18 0.09 against 6.75
0.12 with 0 Cl. Alkalinization half-time (t/2) was 13.4 1.50s with Cl, and
15.7 3.24s with 0 Cl, and base flux into the lumen (JQH) was 0.18 0.02
(N = 25) nmol/cm2 s with Cl and 0.09 0.017 (N = 17) nmol cm2 s
with 0 Cl. pHs and J0 were significantly (P C 0.05) reduced with 0 Cl
perfusion, suggesting the presence of Cl-dependent bicarbonate secretion
in the apical membrane of alkalotic BRB rats. During luminal pump-
perfusion with phosphate Ringer solution at pH 6 in alkalotic Wistar rats,
where luminal Cl might be kept at lower levels than during stationary
perfusion, J0 was significantly reduced by 0 Cl from 43.1 14.6 to 23.1
9.7 pmol/min' mm. These data suggest the presence of Cl-dependent
bicarbonate secretion in cortical distal tubule, particularly in alkalotic
Brattleboro rats.
Rapamycin (RPM) induced tolerance in ALO and aenograft models.
S.A. Bobbio, 1.0. Porter, J.O.M Pestana, and A.P. Monaco, Nephrology,
Escola Paulista de Medicina, São Paulo, BraziL Anti-lymphocyte serum
(ALS) and donor bone marrow (BM) prolong graft survival, an effect
which is enhanced by previous thymectomy of the recipient. B6AF1 mice
thymectomized (THY) or not (non-THY), received ALS on days —1 and
+2, BM on day +7, and RPM from day +9 to +21, relative to C3H/He
skin allograft or Wistar-Furth skin or islet xenograft on day 0. Indefinite
survival of skin allografts was obtained in the ALS, BM and RPM treated
group, an effect identical to that of the THY, ALS-treated, BM injected
group. Forty-five percent of skin xenografts in non-THY recipients treated
with ALS + BM + RPM survived for more than 45 days, whereas in the
THY recipients, MST was 83 days. In islet xenografts RPM was effective
when given alone and with ALS induced indefinite survival (>150 days).
The immunologic status of allorecipients was assessed 14, 30, 60 and 100
days post-grafting: evidence of suppression could be found on day 60 in
the ALS, BM and RPM treated group; in this group, frequency and
number of cytotoxic T lymphocytes specific for donor (C3H/He) antigens
were depressed on day 60 post-grafting, but returned to normal by day
150, when the graft was still in perfect conditions, whereas THY,
ALS-treated, BM injected recipients were still depleted on day 150.
Unresponsive animals treated with ALS, BM and RPM carrying skin
grafts for more than 150 days rejected 3rd party grafts in a normal fashion,
whereas THY, ALS-treated, BM injected mice did so in a slightly
prolonged fashion, suggesting that RPM treated recipients were more
specifically suppressed. We conclude that RPM can substitute THY in less
immunogenic models like allografts and islet xenografts. In the ALS, BM
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and RPM treated animals clonal anergy and suppressive mechanisms
interact to maintain long-term grafts, whereas in THY, ALS-treated, BM
injected recipients, clonal reduction appears to predominate.
Enhanced peripheric renin activity identifies high-renin hypertension
in renal transplanted patients with native kidneys. MC.B. Teixeira, E.
David-Neto, E. Sabbaga, and S. Arap, Renal Transplantation Unit, Division
of Urology, Hospital das ClInicas, University of São Paulo Medical School,
São Paulo, Brazil. Basal and enhanced peripheric renin activity (0 and 90
mm) measured during the oral captopril test (25 mg) has been used to
identify renovascular hypertension in non-transplanted patients. No avail-
able method exists to identify the patients who could benefit of the
removal of native kidneys, although it is clear that some of these kidneys
produce large amounts of renin. We used the captopril test and enhanced
peripheric renin activity (PRA) to investigate systemic arterial hyperten-
sion in renal transplanted patients with normal renal function (Scr < 2
mg/dl), in the presence the native kidneys, to validate this test in renal
transplanted hypertensive patients. Twenty-nine patients (16F, 13M), with
1 to 2 years of renal transplantation, were randomly selected to be tested.
Eleven patients were normotensive (N) (diastolic blood pressure < 95 mm
Hg) and 18 were hypertensive (H). Both groups were identical for sex, age
(N = 39 15 vs. H = 32 15, P = NS), Scr (N = 1.1 0.26 vs. H = 1.3
0.39, P = NS), number of patients on CsA and both CsA (N = 4.39
2.37 mg/kg vs. H = 4.26 0.83, P = NS) and steroids (N = 0.16 0.04
mg/kg vs. H = 0.18 0.05, P = NS) dosages. In none of the N patients,
but in 10/18 (55%) of H patients, a fall in diastolic blood pressure (>20
mm Hg) was seen during the captopril test (P < 0.01). Basal PRA was
higher (H = 8.4 6.7 ng/ml/hr vs. N = 3.6 3.8, P = 0.04) and more
frequent (H = 15/18 vs. N = 5/11, P = 0.03) in H than in the N patients.
The PRA increased after captopril test (CT) in H (17.2 10.5) but not in
N (3.6 3.3) patients (P = 0.001), while 14/18 (78%) of H patients had
positive PR.A (Laragh criteria). Nine (50%) H patients had +CT/+PRA,
5 (28%) —CT/+PRA, 3 (17%) —CT/—PRA and 1 (5%) +CT/—PRA.
When comparing the 9 H patients with positive CT to the other 9 H
patients with negative CT, the former group had similar basal PRA (7.8
4.9 vs. 9.2 8.7, P = NS) but a higher enhanced PRA (20.4 10,9 vs. 13.3
9.1, P = 0.02) than the latter. These data indicate that 50% of the H
renal allograft recipients with normal graft function and the presence of
native kidneys fulfill the criteria for renovascular hypertension and could
be candidates for bilateral nephrectomy of native kidneys.
Renal transplantation in systemic lupus erythematosus (SLE). A study
of 40 cases compared with a case-control group. L.S. Azevedo, J.E. Romao
Jr., L.E. Ianhez, L.B. Saldanha, and E. Sabbaga, Renal Transplantation
Unit, University of São Paulo Medical School São Paulo, Brazil. We studied
40 patients with SLE submitted to 42 renal transplants since May 1975,
with a minimum 1 year follow-up. Thirty-one (78%) were females. Two
received a 2nd transplant. Donors were: living related 26 (65%), cadaver
10 (25%), and living unrelated 4 (10%). A case-control group was selected
for comparative purposes, matched for the same sex, race and kind of
donor. Ages were similar (5 years older or younger) and they had been
transplanted at the same period. All had chronic glomerulonephritis.
Other renal diseases were excluded. Survival was similar for both groups
(83% and 86% at 5 years for patients and 71% and 75% for kidneys). Side
effects possibly related to SLE were: arthralgia 6 cases in both cases,
leukopenia in 5 SLE patients and 7 control. Thrombocytopenia occurred
in 1 SLE patient with positive anti-platelet serum antibodies. Three SLE
patients developed proteinuria, of which renal biopsies were compatible
with recurrence of lupus glomerulonephritis. Antinuclear serum antibod-
ies levels varied widely and no defined pattern could be established. There
was a tendency towards low levels of complement C4. It was concluded
that kidney transplantation in SLE patients had a similar outcome to the
case-control group with a low rate of recurrence of renal and systemic
disease.
Post-renal transplant diabetes mellitus: Clinical characteristics and
analysis of risk factors. G.M. Matos, D. Saitovich, R. Sesso, and J.O.M.
Pestana, Escola Paulista de Medicina, São Paulo, Brazil. Objective: To
study the incidence, clinical features and possible risk factors involved in
post-renal transplant diabetes mellitus (PTDM). Methods and result: 477
non-diabetic adult renal transplant recipients, whose graft survival was> 6
months, were studied retrospectively. PTDM (defined as 3 fasting glyce-
mias > 140 mg/dl) developed in 42 patients (9.2%), and 52% were
diagnosed by 3 month post-transplantation. One patient presented with
diabetic ketoacidosis. Of 42 PTDM patients, 25 (60%) required insulin
therapy from the onset, but only 11(26%) remained insulin-dependent.
Nineteen (45%) were controlled with oral hypoglycemic agents or diet,
and in 12 (28%) PTDM was transient, achieving glucose normalization
after a follow-up period of 1 to 8 months. In order to assess the risk factors
involved in PTDM, a randomized group of 84 non-diabetic transplant
patients were compared with PTDM patients through a step-wise multiple
logistic regression analysis. Older age (>36 years), black race, body mass
index (> 25) at 6 months post-transplant, positive family history of
diabetes and higher dose of corticosteroid during induction of immuno-
suppression (prednisone > 1.2 mg/kg/day) were significant and indepen-
dent of risk factors for development of PTDM. Cumulative dose of
methylprednisolone only approached significance. Patient gender, donor
source, cumulative number of rejection episodes, use of cyclosporine,
diuretic, and betablocking agents were not associated with significant risk
for PTDM. Conclusion: PTDM developed in 9.2% of renal allograft
recipients, and was mostly not transient. Older age, black race, overweight
and heredity for diabetes mellitus were independent risk factors. Cortico-
steroid doses appear to be important in the pathogenesis of PTDM.
ICAM-! expression in parenchymal cells of renal allografts. R.C.
Manfro, L.F. Gonçalves, C.A. Prompt, and L.A. Moura, Renal Transplant
Unit, Hospital de ClInicas de Porto Alegre, Federal University of Rio Grande
do Sul, PortoAlegre, Brazil. ICAM-i (intercellular adhesion molecule-i) is
a LFA-i (lymphocyte function-related antigen-i) ligand, and among other
molecules is important in cell-cell adhesion in an antigen-independent
way. In this study ICAM-i expression was evaluated in parenchymal cells
obtained by fine-needle aspiration biopsies, sequentially performed in 10
renal transplant recipients. The aspirates were processed by a three step
indirect immunoperoxidase technique employing an anti-ICAM-1 mono-
clonal antibody. The results expressed as percentages of peroxidase
positive cells are summarized in the table.
Clinical situation
Number
of exams
Average
SD
Stable renal function 28 23.5 8.3
Acute tubular necrosis 17 20.7 10.6
Acute rejection 18 33.9 12.8
Acute rejection (steroids) 14 31.6 11.9
Acute rejection (OKT3) 9 24.9 21.9
The average percentage of ICAM-1 expression was higher, whether or not
in treatment, during rejection episodes (31.2 14.9), than during acute
tubular necrosis or stable renal function periods (22.8 9.2; P < 0.01).
These results permit us to conclude that there is an increased ICAM-1
expression during acute rejection of renal allografts.
Bone mineral density in hypercalciuric children: 5 years follow-up. HG.
Perrone, M.M.S. Marone, A.C. Bianco, L.F. Malvestiti, J. Toporovski and N.
Schor, Departamento de Pediatria/Nefrologia da Santa Casa de SP, Disci-
plina de Nefrologia da EPM e Unidade de Densitometria Ossea, São Paulo,
Brazil. The bone mineral density (BMD) was prospectively evaluated in 46
children with idiopathic hypercalciuria (IH) during a period of 18 to 60
months. Nineteen children presented with nephrolithiasis and 27 pre-
sented with hematuria due to IH. Lumbar spine BMD (L2-L4), femoral
neck and total body, as well as 24 hour urinary calcium were performed
every 6 months. The children were divided into 3 groups: controlled
children (C, N = 22), those who presented only one hypercalciuric urinary
episode; irregular controlled (IC, N = 16), children who presented
normocalciuric and hypercalciuric during periods; and not controlled (NC,
N = 8), children always hypercalciuric. The results from BMD (L2-L4)
showed for groups C and IC significant increase value, compared to NC
group (P < 0.029 and 0.025, respectively). There were no significant
changes between the groups related to femoral neck and total body BMD.
However, expressing the results as "z" score, in groups C and IC a
significant increase was found in L2-L4 BMD related to NC children (P <
0.034 and 0.002). Femoral neck presented significant increase between C
and NC groups (P < 0.034). No significant changes for total body were
found. Moreover, if we consider different groups as nephrolithiasis
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children (I), hematuric children (II) and hematuric children who devel-
oped kidney stone (III), significant changes can be achieved for total body
BMD between groups I and III (P = 0.006), as well as if the values are
expressed as "z" score (P = 0.056). In summary: (1) Not controlled
children presented less BMD improved; (2) careful evaluation is necessary
in IH children with regard to bone development and calcium metabolism
in order to prevent bone loss.
Histological pattern of different types of renal osteodystrophy in 683
uremic patients studied between 1985 to 1993. V. Jorgetti, R.C. Pereira,
A.A. Santos, L.M Reis, A.M Misael, and MM. Machado, Servico de
Nefrologia, Faculdade de Medicina da Universidade de São Paulo, São
Paulo, BraziL Between 1985 and 1993, we analyzed 683 bone biopsies of
patients with chronic renal failure who presented renal osteodystrophy.
After tetracycline labeling a bone biopsy was taken from the anterior iliac
creast. The fragments were included in methylmetacrylate. The sections
were examined using a regular microscope and ultra violet light after
staining with toluidine blue and aluminon. The patients were classified
according to the histology of: adynamic (AD), osteomalacia (OM), mixed
(DM), and osteitis fibrosa (OF). The table describes the histological types
observed, as well as a percentage of the patients with aluminum intoxica-
tion [aluminum surfaces (Als) more than 20%].
1985 1986 1987 1988 1989 1990 1991 1992 1993
AD % 08.6 13.3 13.9 15.6 27.4 34.6 14.8 16.6 25.0
DM % 10.3 0.00 09.6 04.9 08.0 04.0 07.4 06.4 08.6
OM % 50.0 50.0 39.7 39.2 34.6 28.5 18.4 26.9 17.6
OF % 31.0 36.6 36.5 40.1 29.8 32.6 59.2 50.0 50.0
Ms % 79.0 56.6 68.8 60.7 66.1 53.0 30.8 37.1 39.7
In conclusion, we observed a significant inversion of the incidence of the
histological types analyzed; this means a decrease of the OM, an increase
of the OF, and a decrease of the incidence of aluminum intoxication.
Chronic aluminum intoxication: Lymphocyte subsets and allogenic
immune response in rats. C. Tzanno-Martins, L.S. Azevedo, N. Oru V.
Jorgetti, E. Sabbaga, M Marcondes, and A.J.S. Duarte, Immunology and
Nephrology Divisions, University of São Paulo Medical School, São Paulo,
Brazil. High levels of aluminum in urine, bone and serum had been
correlated with a higher susceptibility to infection, a low number of
rejection episodes after renal transplantation, and better allograft survival.
The purpose of this study was to evaluate the allogenic immune response
in vitro and in lymphocyte subsets from Lewis rats chronically intoxicated
by aluminum. The animals were divided into 4 groups: control rats with
normal renal function (NRF), NRF intoxicated by aluminum (NRF + Al),
rats with chronic renal failure (CRF), and CRF intoxicated (CRF + Al),
A subtotal nephrectomy model was used to obtain experimental uremia. A
0.25 M MCi3 solution was injected in the peritoneal cavity to obtain
aluminum intoxication. Al was indicated in bones by aluminum and
solochromoazurine. Bidirectional and unidirectional mixed lymphocyte
cultures were done using NRF, NRF + Al, CRF, and CRF + Al spleen
cells versus spleen cells from Wistar Furth rats. The mitogenic stimulation
was done with concanavalin A (5 sg/ml), and lymphocyte subsets were
analyzed using monoclonal antibodies against W3/13 (T lymphocytes),
W3/25 (helper lymphocytes), Ox8 (cytotoxic/suppressor cells) and B
lymphocytes. We verified: Al in bones of intoxicated rats (P < 0.05),
osteomalacia in CRF + Al group, no differences in bi- and unidirectional
mixed cultures, decreased mitogenie response in CRF, NRF + Al and
CRF + Al (P < 0.05), decreased W3/13 population in CRF + Al and
NRF + Al (P < 0.05), and decreased W3/25:Ox8 ratio in the CRF +Al group (P < 0.05). These results suggest that aluminum intoxication
could have an immunosuppressive effect in intoxicated animals with NRF
or CRF.
Effect of PTH and calcium (Ca) on urinary acidification. F,Z. Gil, V.L.
Costa Silva, and G. Malnic, Disciplina de Fisiologia Renal e Termometabo-
logia, Escola Paulista de Medicina and Departamento de Fisiologia e
Biofisica, Universidade de São Paulo, São Paulo, BraziL H ion secretion in
the proximal tubule is affected by several factors, among them Ca, which
exert an important role on this tubular function. In a previous study from
our group, it was shown that in thyroparathyroidectomized rats (TPTX),
the kinetic acidification parameters were significantly changed: the half-
time of acidification (t/2) was increased and the bicarbonate reabsorptive
flux (JHco3) was impaired; these parameters were partially corrected when
the calcemia returned to normal levels by oral Ca supplementation. In this
study, the tubular lumen was perfused with different Ca concentrations, in
a range from 0.0—1 mi (CaO to Cal). In some experiments the calcium
ionophore A23187 was added to the luminal solution, and in the others
EGTA was added. The following results were obtained:
CaOEGTA CaO CaO.l CaO.1A23187
t/2
HCO3
7.83 0.92
1.36 0.14
4.60 0.43
2.28 0.22
4.08 0.14
2.29 0.12
4.83 0.38
2.77 0.24
t12J03
CaO.5
4.95 0.36
2.18 0.16
CaO.5A23187
4.65 0,37
2.32 0.18
Cal
5.44 0.17
1.90 0.07
Ca1A187
5.34 0.26
1.96 0.11
The different Ca concentrations present in the perfusion solution did not
affect the parameters of acidification, meaning that a minimum amount of
the ion is necessary to keep the acid excretion at adequate rates. However,
when Ca was eliminated from the perfusion solution by adding EGTA, the
kinetic parameters were very similar to those obtained in the TPTX model
(t/2 = 8.38 0.45 and HCO3 = 1.10 0.08). These results indicate that
low levels of intracellular Ca, irrespective of the adopted experimental
model, impair the secretion of H and that the level of intracellular Ca is
affected by the luminal concentration of this ion.
Bone histomorphometric and bone mineral content in idiopathic
hypercalciuria patients. AM. Misael, L.M Reis, R.C. Pereira, A. Borelli, A.
Andnolo, E. Sabbaga, V. Joigetti, S.M. Trecco, and YC. Baxter, University of
São Paulo, São Paulo, Brazil. The most common metabolic abnormality
found in recurrent renal stone formers is hypercalciuria; they may also
display abnormal bone metabolism. We studied 12 patients (6 males, 6
females, aged 31.5 11.7years) with calcium calculi, and calciuria (three
consecutive 24 hr collections >4 mg/kg/day; 300.4 101.5 mg/24 hr), on
an uncontrolled diet. All patients had normal renal function and normal
plasma Ca, P and alkaline phosphatase. In order to evaluate bone mineral
density (BMD), dual photon absorptiometiy in lumbar spine and femoral
regions was performed, and the results were compared to age, sex, weight
and ethnic matched controls. The BMD was decreased in 6 patients. In
addition, histomorphometric analysis of bone was performed after double
tetracycline labeling. The control data for bone histology were obtained
from 12 healthy subjects, sex and age matched, who died from violent
deaths. Osteoid surface and eroded surface were significantly increased in
hypercalciuric patients compared to the control group (15.6 X 9.5 and 7.6
x 4.2; P < 0.05). The patients also had a moderate mineralization defect(reduced bone formation rate = 0.07 0.04 and prolonged mineralization
lag time = 38.0 30.0 days). In conclusion, the histomorphometric
analysis revealed signs of a moderate mineralization defect (increased
osteoid thickness, prolonged mineralization lag time) and an increased
extention of eroded surfaces.
Expression of cytokines and growth factors in renal biopsies from
patients with ANCA-positive vasculitis and IgA nephropathy. I.L. No-
ronha, Z. Niemir, K Kruger, H Stein, E. Ritz, and R. Waldherr, Depts. of
Pathology and Internal Medicine, University of Heidelberg, Heidelberg
Germany. Cytokines and growth factors are supposed to play an important
role as mediators of inflammation and as progression factors in various
renal disorders. In the present study, we evaluated the local production of
these factors by using immunocytochemistry and in situ hybridization.
Cryostat sections from 22 patients with systemic ANCA-positive vasculitis
and 30 patients with mesangial IgA glomerulonephritis were analyzed.
1'NF-cx, IL-1/3, IL-2R and IFN-y expression was detected in renal biopsies
from patients with vasculitis with active lesions, particularly in cellular
crescents, in interstitial mononuclear cells as well as infiltrating cells
surrounding blood vessels with fibrinoid necrosis. On the other hand, in
renal biopsies from patients with inactive lesions, there was a marked
expression of PDGF, PDGF-R and TGF-13, particularly in glomeruli with
fibrous crescents and in areas where fibrosis was evident. In IgA-GN
biopsies, an increased mesangial reactivity for PDGF, PDGF-R and
TGF-/3 was present in areas with mesangial expansion. PDGF and
PDGF-R expression correlated with mesangial proliferation, whereas
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TGF-J3 positivity was related to an increase in extracellular matrix. These
results suggest that the in situ TNF-a, IL-1$3, IL-2R and IFN-y expression
reflects marked immunological activation and that these mediators may
play a role in the acute phase of renal lesion. The PDGF, PDGF-R and
TGF-3 expression may be important in the development of mesangial
proliferation as well as the production of extracellular matrix.
The effects of x.rays on progression of renal disease. V.P. C. Teixeira,
H.R.C. Segreto, C. V. Razvickas, and N. Schor, Nephrology Division, Escola
Paulista de Medicina, São Paulo, Brazil. In order to evaluate the effects of
x-rays on the progression of renal disease, male Munich-Wistar rats
(MWRL, N = 7) were submitted to 5/6 nephrectomy and the remnant
kidneys were directly x-irradiated with 6 Gy, in a single dose, through a
linear accelerator 6 MeV. Studies of whole kidney function [glomerular
filtration rate (GFR), renal plasma flow (RPF) and total vascular resis-
tance (TRVR)] and per nephron [single-nephron glomerular filtration
rate (SNGFR) and glomerular capillary hydraulic pressure (P0)] were
performed 60 days after irradiation. The control group (MWRC, N = 7)
underwent the same procedures and was sham irradiated. There was a
significant increase in GFR (0.085 0.09 vs. 0.48 0.06, P < 0.05) and
RPF (2.95 0.34 vs. 1.72 0.19, P < 0.05) due to a marked reduction in
TRVR (26.74 3.62 vs. 45.17 6.24, P < 0.05). The SNGFR also
presented a significant elevation (65.45 5.97 vs. 43.14 4.13, P < 0.05),
in spite of PGC decrease (38 1 vs. 47 1, P < 0.05). The results suggest
that x-rays caused a significant improvement in renal function of remnant
kidneys.
Ischemia.reperfusion and complement activation in cadaveric kidney
transplantation: Immunohistochemical study. F.C.B. Cavalcant4 M
Yokoo, F,J. Paula, E. Sabbaga, S. Arap, M. Marcondes, and E.BA Prado,
Renal Transplantation Unit, Laboratory of Renal Physiopathology, University
of São Paulo, São Paulo, Brazil. Cadaveric kidney transplantation is an
ideal situation for analysis of ischemia-reperfusion impact over several
biological systems related to ischemic cellular injury. Local complement
activation has been demonstrated in myocardial ischemia (deposition of
terminal C5b-9 complex or MAC, expression of regulatory proteins, DAF
and CD59). We analyzed MAC deposition, CD59 and 132-integrin LFA-la
expression and macrophage (MO) infiltration in renal biopsies obtained
40 minutes after renal graft blood reperfusion ("zero" biopsy). We used
monoclonal antibodies and the alkaline phosphatase-anti-alkaline phos-
phatase (APAAP) procedure in frozen tissue sections. We studied 10
patients divided into two groups: G.A (N = 5) (grafts perfused with
Acquatella solution), and G.B (N = 5) (perfusion with University of
Wisconsin solution). There were no statistically significant differences
between groups in relation to age (33 11 vs. 37 15 years), sex (2 men/3
women vs. 2 men/3 women), presence of early diuresis (5/5 vs. 5/5), need
of dialysis in the first week (0/5 vs. 1/5), time of cold preservation (21 4
vs. 28 7 hours) and frequency of cell-mediated rejections (3/5 vs. 3/5).
Acute tubular necrosis was more frequent in G.A (4/5 vs. 2/4) (P < 0.05).
Statistically significant differences were seen in the deposition of MAC
(G.A 5/5 vs. G.B 0/5) (P < 0.05) and expression of LFA-la (G.A 5/5 vs.
G.B 0/5) (P < 0.05). Differences in expression of MO were also significant
(G.A 5/5 vs. G.B 1/5) (P < 0.02). CD59 was identified in 2 patients of G.A.
Our results are suggestive of differences in mechanisms of cell injury by
local complement activation. The number of patients and the time of
follow-up are not sufficient to analyze long-term influence.
In situ expression of cytokines in renal cell carcinoma (RCC). J.L.
Noronha, K Kruger, H. Stein, S. Pommer, and R. Waldherr, Depts. of
Pathology and Urology, University of Heidelbe, Heidelbeig, Germany.
There is strong evidence that immune mechanisms play a role in the
growth and progression of carcinoma. In this context, the participation of
cytokines in the immune surveillance against tumors is of note. Cytokines
may have either inhibitory or progressing influences on tumorigenicity. In
order to evaluate the local cytokine production in renal carcinoma, 20
nephrectomy specimens from patients with primary renal cell carcinoma
were examined (including 18 nonpapillary clear cell carcinomas and two
papillary chromophilic carcinomas). The expression of cytokines was
analyzed at the protein (imniunohistochemistry) and mRNA level (PCR
and in situ hybridization). Cytokine expression was detected in mononu-
clear interstitial cells as well as tumor cells. TNF-a, IL-113, IL-2 and IFN-'
positivity was observed, respectively, in 86%, 100%, 86% and 86% of RCC
cases without metastases. On the other hand, cytokine expression was
observed in all renal samples obtained from patients with RCC with
extrarenal metastases. These preliminary results demonstrate that TNF-a,
IL-lp, IL-2 and IFN-7 are locally produced in RCC, particularly in cases
with metastases. Further studies are necessary to elucidate whether the
local production of cytokines is related to the metastatic capacity and the
clinical behavior of RCC.
Cyclosporine A (CsA) in delayed type hypersensitivity reaction (DT}I).
L.C.F. Andrade, M.A.F. Montesano, L. Ribeiro, L. Cangussu, and M.G.
Jordao-Bastos, Renal Unit, University Hospital and Immunology Depart-
ment, Universidade Federal de Juiz de Forq, Juiz de Fora, Brazil. CsA is a
potent immunosuppressor and is used to prevent allograft rejection,
graft-versus-host disease, and some forms of autoimmune diseases. CsA
blocks the immune response (IR) through inhibition of interleukin-2
production by recently activated T cells. D1'H is a form of IR mediated by
macrophage activated by lymphokines released by T cells, and can be used
as model to study several aspects of cellular immunity. This study assessed
the effects of CsA in the JR to 2 immunogens: 1'NBS and Ovalbumin
(OA). BALB/c mice, 16 weeks of age, were obtained from the animal
facility of The Centro de Biologia da Reproducao, U.F.J.F. DTH was
induced by priming the animals with subcutaneous injection, bilaterally,
into the dorsum. Six days after priming, these mice were challenged with
TNBS or OA into the footpad. Twenty-four hours after challenge, the
thickness of both footpads was measured using a micrometer. Results
were expressed in DTH units (U) defined as a difference of 0.001 mm in
the thickness of injected and uninjected footpads. Control animals re-
ceived no treatment except the immunogen at day of challenge. Based on
the type of treatment and the immunogen used, the animals were divided
into 6 groups: group 1 (TNBS + C5A); group 2 (TNBS); group 3 (control
for TNBS); group 4 (OA + CsA); group 5 (OA); and group 6 (control for
OA). CsA (30 mg/kg/day) was administered intraperitoneally, from D_1 to
D6. After the reading at D7, the mices' footpads were removed for
histopathology. Results: Three hours after the challenge, the IR to OA
was exacerbated, and attenuated to TNBS; After 24 hours, the IR to both
immunogens was inhibited by the dose of CsA used; The DTH to CsA is
slow and resembles that seen in tuberculin; Polymorphonuclear leukocytes
were the main cells found in the inflanunatory infiltrate in the mice's
footpads in both types of DTH, suggesting that CsA does not abrogate the
inflammatory reaction directly.
Free radical evaluation of lipidic peroxidization in children with
nephrotie syndrome. M.M.R. Chinelato, S. Percäno, C. Zuliani, A. Lebi,
VR. Mello, J. Felippe Jr., and J. Toporovski, Depto. de Pediatria da Santa
Casa de São Paulo, Setor de Nefrologia Infantil Depto. de Ciências
FisiolOgicas da Faculdade de Ciências Mëdicas da Santa Casa de São Paulo,
São Paulo, Brazil. Nephrotic syndrome is considered a common presen-
tation of a variety of clinical situations characterized by increased renal
permeability to protein filtration. Ninety percent of the cases in childhood
are idiopathic. Recent studies show the participation of free radical
glomerular injury. The aim of this study was to evaluate the presence of
free radicals in children with nephrotic syndrome through lipidic peroxi-
dization. Forty-one patients from the Pediatric Nephrology Unit of "Santa
Casa de São Paulo" and 10 controls were studied, ages varying from 3 to
14 years. Children were divided in 3 groups: group 1 (control), N = 10, age
= 11(2.6) years; group 2 (complete remission), N = 19; age 10(2.1) years.
Group 3 (symptomatic) N = 22, age = 9 (4.2) years. All of them had
normal renal function. The lipidic peroxidization was evaluated by malon-
dialdehyde dosage. Results: Control group: 441 (95) ng/ml; group 2: 329
(169) ng/ml; group 3: 903 (470) ng/ml. The statistic analysis showed
significant differences between the control and group 3 (P < 0.01) and
between groups 2 and 3 (P < 0.001). The difference between the control
and group 2 were not statistically significant (P > 0.1). The authors
conclude that free radicals may play an important role in the nephrotic
syndrome pathogenesis and the therapy against free radicals may be a
valuable therapeutic perspective in this disease.
Distal renal tubular acidosis (DRTA): Experience of 14 cases. E.M
Lima Verde, EM. Lima Verde, Z.M.N. Quezado, and E.F. Daher, Instituto
de Nefrologia do Ceará, Faculty of Medicine of Ceará, Ceard, BraziL
Fourteen patients with DRTA were analyzed. Clinical data: polyuria
92.3%, polydipsia 76.9%, nocturia 77%, failure of growth 50%, bone
deformities and stone elimination 14.2% of the patients. Laboratory data
(mean SD): serum-sodium 136 4.1 mEq/liter, potassium 3.2 0.8
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rnEq/liter, calcium 9.4 0.6 mg/dl, phosphate 3.1 0.9 mg/dl, alkaline
phosphatase 143 116 lU/mi, urea 26 12 mg/dl, creatinine 0.95 0.39
mg/dl, uric acid 4.1 1.3 mg/dl. Twenty-four hour urine: volume 2179
983 ml, sodium 104 34 mEq, potassium 28 7 mEq, calcium 9.5 mg/kg,
phosphate 348.5 95 mg, and protein 308 377 mg. Clearances of uric
acid, phosphate and creatinine were 12.4 6.9, 22 8.2 and 89 28
ml/minll.73 m2, respectively. Phosphate tubular reabsortion was 71.5
15.5%. Maximum urinaly osmolality was 656 363 mOsm/kg 1120, and
acidification urinaly test was: fast value-serum pH 7.29 0.08, HC03
17.1 4.9 mEqlliter; urine pH 6.7 0.5, TA 116 5.5 sEq/min and
NH4 32.4 18 Eq/min. Eight hours after: serum pH 7.2 0.008,
HC03 15.3 4.9 mEq/liter; urine pH 6.3 0.42, TA 24 10 Eq/min,
NH4 42.3 23.2 iEq/min. The patients were treated with NaHCO3 5 to
10 g/day and KCI. There was growth and bone age improvement.
Relationship between acute pyelonephritis and blood groups and lILA
DQA. MH. Albarus, F.M. Saizano, and NP. Goidraich, Department of
Genetics, Universidade Federal do Rio Grande do Sul and Pediatric Nephrol-
ogy Unit, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. The aim
of this prospective study was to compare the prevalence of blood groups
ABO, Rh, MN, P, Lewis and secretor state and of HLA DQA markers in
infants with acute pyelonephritis (APN) due to Escherichia cob and in a
control group. The inclusion criteria were: Caucasian; age from 1 up to 12
months. APN was defined, by a positive urine culture and fever, in an
infant. Sixty-five infants (44 females and 21 males) with APN were studied.
In all, urine for culture was collected by suprapubic bladder puncture.
Blood and saliva samples were obtained from each patient for determi-
nation of blood groups and HLA DQA typing. The urinary tract was
assessed by ultrasound, micturating cystography and DMSA renal scan.
According to the findings of these tests, patients were classified into 2
groups: (1) normal urinary tract: N = 40; (II) with primary vesicoureteric
refiux: N = 25, Up to now, HLA DQA was performed in 44 infants (27
from group I, 17 from group II). The control group was formed by 1,678
Caucasians from the same geographic area. There was no significant
difference in the prevalence of blood groups among infants with APN with
normal urinary tract and with vesicoureteric reflux. In the 44 infants
studied up to now, there was no significant difference concerning HLA
DQA typing. There were no significant differences among infants with
APN and the control group. Contrary to other reports in the literature, we
did not find any significant association between blood groups and APN in
infants.
Impact of new disconnect systems on the incidence of pediatric CAPD
peritonitis. R.B. Rocha, R.A. Aranda, H. Abensur, V. Koch, MD. Fujimura,
M.C.M. Castro, J.E. Romão Jr., V. Okay, M Marcondes, and E. Sabbaga,
Dept. of Pediatrics and Nephrology, Hospital das ClInicas, São Paulo, Brazil.
We analyzed two groups of children on CAPD. The first one (01) was
composed of 31 children using the standard system and foltowed in the
period between January 1984 to October 1990. The second one (02) was
composed of 17 children using the newer disconnect systems (4 0-set-
Fresenius, 12 SDD-Baxter, and 1 ANDY-Fresenius), followed between
January 1991 and December 1993. The mean age in Gi was 6.3 years (SD
= 3.9), and in 029.0 years (SD = 5.1). In Gi, 17/31 children (54.8%) were
transplanted, 6/31 (19.4%) switched to hemodialysis, 4/31 (12.9%) died,
3/31 (9.7%) remained on CAPD, and 1/31 (3.2%) recovered renal
function. In 02, 10/17 children (58.8%) remained on CAPD, 4/17 (23.5%)
were transplanted, 1/17 (5.9%) switched to hemodialysis, and 1/17 (5.9%)
died. The rate of peritonitis was 1 episode by 9.1 patient/month in 01, and
1 episode by 15.3 patient/month in 02. In Gi the organism causing
peritonitis was gram-positive in 67,2%, gram-negative in 14.8%, yeast in
3.3%, and 14.7% of the cultures resulted in negatives. In 02 peritonitis
was caused by a gram-positive organism in 53.3% of the cases, gram-
negative 20%, and 26.7% of the cultures resulted in negatives. We
conclude that the disconnect systems have contributed significantly to the
reduction of peritonitis rate in children on CAPD.
Cyclosporine treatment in Idiopathic nephrotic syndrome children.
V.R. Mello, J. Karter, H.C. Perrone, D.C. Thomé, and J. Toporovski,
Departamento de Pediatria/Nefrologia da Santa Casa de São Paulo, São
Paulo, Brazil. A total of 12 children with idiopathic nephrotic syndrome
(INS) received cyclosporine. Five were female, aged from 18 months to 15
years (X = 7.9 years). Kidney biopsy presented: 4 segmental glomerular
sclerosis (SOS), 7 minimal change nephrotic syndrome (MCNS), and 1 not
conclusive. Seven children had steroid dependent nephrosis (SD) and 5
were steroid non-responders (SNR). Cyclosporine was given at a dose of
5—6 mg/kg body wt in 2 daily doses for a period of 6 to 12 months.
Cyclosporine was given in combination with prednisone 35 mg/rn2 body wt,
on alternate days. Renal function was normal in all observed children. All
SD children (7/7) went into remission, but 4/7 relapsed after 2 to 8 months.
Three children failed to respond to the cyclosporine therapy. Hypertri-
chosis was observed in 7 patients. Hypertension was not observed. The
results obtained with cyclosporine in INS in our department confirm the
importance of this drug as being effective as a third line drug in
steroid-dependent INS.
Dialysis adequacy: A comparison between hemodialysis and continuous
ambulatory peritoneal dialysis (CAPD). E.M Barim, J.S.T. Caramori,
MJ.D.B. Felippe, A.A. Lopes, P. Barretti, and V.A. Soares, Faculdade de
Medicina, UNESP-BOTUCATU, São Paulo, Brazil. Kt/V is a well accepted
index of hemodialysis adequacy, but its usefulness in CAPD is not yet
established. The aim of this paper was to correlate the Kt/V [Kt/V + (0.08
x residual clearance), where Kt = 24 hr drained volume X D/P(Ura), V =
0.58 body weight (BW)] with the clinical score proposed by Keshaviah et
al (29—36 = adequate; 23—29 transitional; <23 inadequate) in 13 patients
treated by CAPD followed for at least 6 months. The protein catabolic
rate (pcr g/kg/day) was evaluated by: per = 10.76 X GU (Urea generation
mg/mm) + 1.461BW. The same variables were also determined in 15 stable
patients treated by hemodialysis (3 times/week). In both groups the daily
protein ingestion (DPI) was evaluated and expressed as g/kg/day. The
comparison between the 2 groups is shown in the table:
CAPD
(N=13) Hemodialysis(N=15)
KT/V (mean SE) 0.59 0.02 1.13 0.08
Clinical score (median) 30 29
per (mean SE) 1.12 O.1 0.88 0.07
DPI 1.14 0.07 1.0 0.08
ap <0.01
Conclusions: The value of the Kt./V associated with an adequate clinical
score in CAPD is lower than that of hemodialysis. If this difference
depends on higher peritoneal permeability or on a more stable profile of
volemia or biochemistry, values in CAPD patients could not be deter-
mined in this study.
Ilemodialysis and peritoneal dialysis during pregnancy: An analysis of
12 cases. J.E. Romão Jr., C. Luders, S. Kahalle, I. Pascoal, M. Marcondes,
and E. Sabbaga, Hospital das Clinicas, University of São Paulo Medical
School, São Paulo, Brazil. Successful pregnancy outcome is a distinctly rare
occurrence in women requiring chronic dialytic treatment, and the most
adequate dialysis therapy in the management of these pregnant patients
has not been established. During the period of 1989 to 1993 we studied the
outcome of 12 pregnancies in dialyzed female patients (at the University
of São Paulo), with an average age of 28.8 4.0 years (range: 21 to 35
years). Five women had adequate urine volume (> 800 ml/24 hr). Four
patients started dialysis after conception and the remaining 8 pregnancies
were diagnosed after 6 to 72 months on dialysis. Nine women were
maintained on hemodialysis (HD) and 3 on CAPD. The HD schedule was
increased to 3 hours 5—6 times weekly, and CAPD was increased to 6
2-liter exchanges/day. Mean serum urea was 75.6 28.4 mg/cu (range: 45
to 110 mg/di); creatinine was 6.3 3.4 mg/dl (3.3 to 9.8 mg/dl); and
hematocrit was 26.7 3.2 vol% (22—31 vol%). Anemia was partially
controlled with rHuEpo in 3 patients. Significant problems were polyhy-
dramnios in 7 cases (5 HD/2 CAPD), oligohydramnios in 1 (HD),
gestational diabetes in 2 (CAPD), premature labor with spontaneous
abortion at the 19th and 22nd weeks of gestation (1 HD/1 CAPD),
hypertension in 6 (5 HD/1 CAPD), and sterile eosinophilic peritonitis in
1 case. Mean gestational age at delivery in 10 successful pregnancies (8
HD/2 CAPD) was 30.4 weeks (27 to 35 weeks) and mean baby weight was
1.235 g (range 720—2.150 g). No fetal abnormality in babies was observed.
Respiratory distress was observed in 6 infants, with 2 deaths (1 HID/i
CAPD) in the first week after delivery. In this study, successful pregnan-
cies were reported in 66.7% of dialyzed women with uremia, with
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hemodialysis having a better rate of fetal survival compared to CAPD
(77.8% vs. 33.3%).
The effects of high-flux hemodialysis on uremic neuropathy. MA.K
Nader, JA Ehiers, CA Costa, and C.A. Prompt, Department of Nephrology,
Hospital de ClInicas of Porto Alegre, Porto Alegre, Brazil. In patients with
end-stage renal disease, nervous system dysfunction remains an important
cause of disability. f32-microglobulin (132m) has been implicated in the
pathogenesis of uremic peripheral neuropathy (PNP). In this study, serum
132m levels were measured in 9 patients on hemodialysis with cuprophan;
the mean age was 41.9 15.8 years and the mean time of maintenance
dialysis was 11.9 8.6 months. High-flux (HF) hemodialysis with polysul-
fone dialyzers was used in these patients during 6 months in order to
investigate the influence of different membranes on plasma levels of f32m
and PNP. Mean KT/V (1.07 0.137 x 1.09 0.17) and serum J32m levels
(27.7 5.0 X 29.5 4.5) did not differ significantly in both modes of
dialysis. PNP was evaluated by ulnar and median nerve conduction
velocity done at the beginning of the study and 6 months after. There was
a significant improvement of nerve sensory velocity (P < 0.05). These
results suggest that HF hemodialysis with f32m high-permeability mem-
branes can improve the PNP regardless of the levels of j32m.
Effectiveness of fusidic acid in the eradication of Staphylococcus aureus
nasal carriage. S.A. Draibe, MA Dalboni, T V.F. Rabello, SR. Manfredi,
MN. Cendoroglo, ME.F. Canziani, R.C. Sesso, and H. Ajzen, Division of
Nephrology, Escola Paulista de Medicina, São Paulo, BraziL The major
cause of drop-out in continuous ambulatory peritoneal dialysis (CAPD)
patients in our dialysis center is Staphylococcus aureus (S. aureus) perito-
nitis. Most of these patients are chronic nasal carriers of S. aureus. In order
to evaluate the effectiveness of fusidic acid in the eradication of S. aureus
nasal carriage, we studied 44 patients with at least 2 nasal positive cultures
(chronic carriers), 25 on hemodialysis (HD) and 18 on CAPD. Nine
CAPD patients and 16 HD patients were randomly selected for treatment
or no treatment of their nares with 0.5 cm3 of a 2% fusidic acid nasal
ointment 3 times a day for two weeks (first phase), and then 3 times a week
for three months (second phase). CAPD patients applied the ointment in
the catheter exit site also. The control group (10 HD and 9 CAPD
patients) did not receive a placebo. The criteria adopted for eradication
consisted of two negative nare cultures collected 48 and 72 hours after the
first phase. During the first phase, for CAPD patients, eradication
occurred in 7/9 patients treated in the CAPD group (78%) as well as in 0/9
of the controls (P < 0.005). For HD patients, eradication occurred for 7/16
treated patients and 2/10 control patients (NS). After one month in the
second phase, there were new eradications in the hemodialysis group, and
the cumulated eradication occurrence was higher among treated patients
than in control patients (12/15 treated patients vs. 2/9 controls; P < 0.01).
Among those patients who had eradicated S. aureus, there were 2 carriers
of Oxacillin resistant £ aureus. Thus, we can conclude that the fusidic acid
was effective in eradicating S. aureus from the nares of dialysis patients. It
remains to be determined whether this eradication could lead to a
significant reduction in the morbidity and mortality due to S. aureus
infections in this population.
CAPD.—1O years of experience in CDR/Rio de Janeiro. F.R. Alves, R.C.
Dantas, and A. Zagury, ClInica de Doencas Renais (CDR), Fundacao do
Rim F, Rio de Janeiro, Brazil. We present our experience with ten years of
CAPD (August 1983 to August 1993). Data were processed utilizing a
CAPD database (CAPDATA 1.1, F. Rim, Rio de Janeiro/Brazil). One
hundred and seventy-seven patients (88 male and 89 female) were
followed for 92,844 days, totaling 3,095 patient/months. Mean age was 51
25 years (4 days—94 years). Primary renal diseases were: nephrosclerosis(N = 65, 36.7%), diabetic nephropathy (N = 30, 16.9%), chronic GN (N
= 26, 14.7%), obstructive disease (N = 13, 7.3%), and others (N = 43,
24.3%). Treatment methods were: hemodialysis (31%), conservative
treatment (28%), IPD (25%), or other (17%). A total of 246 catheters was
implanted, 176 being two-cuff Tenckhoff, 35 one-cuff Tenckhoff, and 35
"Swan Neck." Three hundred twenty-nine episodes (Epis) of catheter
related infections (CR1) were registered (tunnel 35 and exit-site 294),
yielding an incidence of 1 Epis/9.4 patient/month. Cultures were obtained
in 140 occasions of which S. aureus represented 68% and gram-negative
25%. CR1 episodes were more frequently treated with first generation
cephalosporin (Cf-i, 62%), vancomycin (41%), SMTITMP (24%), and
tobramycin (Th, 17%). Cure was obtained in 80% of the cases. CR1
determined catheter removal in 55 occasions. The whole incidence of
peritonitis was 1 Epis/1i.2 patient/months. Following introduction of the
Y-systems ("0" set and disposable "Y" set, Baxter Co.), the peritonitis
rate was 1 Epis/19.1 patient/month (last 4 years). From the 263 Epis of
peritonitis, 188 were cured (71%). From the 151 cultures obtained,
gram-positive microorganisms were isolated in 109 (71%) (5. aureus in 53
and S. epidermidis in 44), gram-negative in 23%, and fungi in 5%. For
peritonitis first generation cephalosporins (N = 177) and tobramycin (N =
198) were the most usual first line antibiotics. Actuarial survival at 4 years
was 58% for patients, 41% for the technique, and 18% for the catheter.
Results indicate that the introduction of the Y-systems was accompanied
by a reduction in incidence of both peritonitis and peritonitis related
catheter loss (1 epis/78 patient/months vs. 1 epis/41 patient/month in
standard system). As the peritonitis rate is reduced catheter related
infections emerge as a prominent morbidity factor in CAPD.
Protective effect of L.Arginine (L-ARG) on post-ischemic acute renal
failure (ARF). LA Tome, SB. ('ampos, and A. C. Seguro, Laboratório
Pesquisa Básica, Nephrology, São Paulo University, São Paulo, BraziL The
role of nitric oxide (NO) on post-ischemic ARF was studied in rats
subjected to 60 minutes of bilateral renal ischemia. The animals received
intravenous infusion of L-ARG (50 mg/kg) or saline vehicle, at the
beginning of the ischemia and immediately after reperfusion. The exper-
iments were performed 48 hours after reperfusion. The inulin clearance
(ml/min/100 g BW) was higher in L-ARG animals (0.38 0.05) when
compared to control rats (0.14 0.02; P < 0.01). The fractional excretion
of K (FEK) was lower in the L-ARG group (44.0 4.4%) than in the
controls (107.7 24.1%; P < 0.01). The FE of H20 and Na was lower in
the L-ARG group (FEH2O = 1.45 0.38%; FENa = 1.24 0.22%) than
in the controls (FEH2O = 3.98 0.38%; FENa = 1.92 0.6%), but not
statistically significant. These results indicate a protective effect of L-ARG
on GFR, and also suggest tubular protection. Other experiments were
performed to investigate the inhibition of NO synthesis. In this 3rd group,
the animals were injected with L-NAME (2.5 mg/kg) as described above
for L-ARG. The inulin clearance was lower in this group (0.09 0.02),
when compared to the other groups (P < 0.01), as well as the FEH2O
(14.6 7.6%); FENa (6.02 2.9%) and FEK (135.5 26%) were
significantly higher than in groups 1 and 2. These results indicate a
deleterious effect of the NO synthesis inhibition and a protective effect of
L-ARG on post-ischemic ARF. In conclusion, these data confirm an
important role of NO on ARF.
Reactive oxygen species (ROS) are involved in rat tubular hypoxia.
reoxygenation (H/R) injury. L. Yu, P. Gengaro, Ti. Burke, and R. W.
Schrier, University of São Paulo, São Paulo, Brazil, and University of
Colorado, Denver, Colorado, USA. The role of ROS in H/R injury is still
controversial. Most studies have addressed this issue by indirect means
without directly measuring ROS. In this study, we sought to measure
superoxide radical (02) and hydrogen peroxide (H202) in isolated rat
proximal tubules suspension (PT) subjected to 15 minutes hypoxia (H-15)
and 35 minutes reoxygenation (R-35). The influence of superoxide
dismutase (SOD), dimethylthiourea (DMTU) and catalase (CAT), which
are ROS scavengers, on this model was evaluated. Cell injury was
measured by LDH release (%) atbaseline (N-0), H-15 and R-35. LDH in
H/R PT compared to time controls was 10.6 versus 8.5% (N-0, NS), 22.3
versus 12.3% (H-15, P < 0.005) and 34.2 versus 17.9% (R-35, P < 0.005).
02 basal production (0.8 0.3 nmol/mg prot) did not increase after H-15
(0.9 0.1 nmol/mg prot/i5 mm) or R-35 (1.0 0.1 nmol/mg prot/50 miii).
H202 averaged 0.6 0.1 j.tmol/mg prot (N-0) and 1.0 0.1 smol/mg
prot/15 mm (H-is) (both NS vs. controls). After R-35, H2O2 increased to
2.3 0.2 which was higher than controls (1.5 0.1 .rmol/mg prot/50 mm,
P < 0.05). SOD and DMTU did not attenuate LDH release either after
H-iS or R-35. Although CAT did not attenuate LDH release during H-15,
it did during R-35 (31.8 vs. 41.8%, P < 0.01). This protection was
paralleled by a lower H2O2 in CAT-treated PT (1.6 0.1 vs. 2.3 0.2
.rmol/mg prot/50 mm, P < 0.05). In conclusion, ROS, especially H202,
may participate in the pathogenesis of the H/R injury in rat PT.
Hypercholesterolemia enhances hypoxic cellular injury. M 0r4 S.B.
Campos, andA.C. Seguro, Nephrology, LIM-HC FMUSP, São Paulo, Brazil.
Previous studies from our laboratory showed that hypercholesterolemic
rats presented lower inulin clearance (0.08 0.03 ml/min/iOO g) than
normal rats (0.23 0.04), 2 days after 60 minutes renal ischemia. In order
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to verify whether hypercholesterolemia sensitizes tubular cells to hypoxia,
we studied inner medullary collecting duct (IMCD) cell cultures obtained
from rats on a regular diet and on a 4% cholesterol and 1% cholic acid
supplemented diet for 3 weeks (serum cholesterol = 83 10 and 183
18 mg/dl, respectively). The cells were cultivated on RPMI medium and
studied 6 days after plating. Hypoxia was induced by gassing cell plates
with 100% N2 for 60 minutes, and reoxygenation with 95% 02-5% CO2 for
60 minutes. Cell injury was assessed by lactate dehydrogenase release
(LDH %). In cell cultures from normal rats, LDH was 17.8 2.0% after
hypoxia of 24 hours, a value similar to cultures maintained on normoxia
for 24 hours (23.6 6.0%). An increase in LDH was observed when the
cultures were exposed to 24 hours hypoxia followed by 24 hours reoxy-
genation (44.9 4.8%, P < 0.05). Cultures of cells from hypercholester-
olemic rats showed significantly higher values of LDH: 36.3 5.2% after
24 hours normoxia, 50.9 6.0% after 24 hours hypoxia, and 72.2 3.6%
after 24 hours of hypoxia followed by 24 hours reoxygenation. These data
indicate that hypercholesterolemia has a direct effect on IMCD cells,
increasing their susceptibility to hypoxia and reoxygenation injury.
Acyciovir (ACV) and gancyclovir (Gan) administration in rats: Gloiner-
ular hemodynamic evaluation. M.F.F. Santos, O.F.P. Santos, MA. Boim,
C. V Razvickas, H. Ajzen, and N. Schor, Nephrology Division, Escola
Paulista de Medicina, São Paulo, Brazil, The high recurrence index of virus
infections in immunocompromised patients has improved the use of
specific antiviral drugs, such as ACV and Gan. Thus, considering the
potential side effects of these drugs, this study has evaluated the ACV and
Gan effects on glomerular hemodynamics of rats submitted to a chronic
treatment of ACV (N = 10, 50 mg/kg/day, 5 days), Gao (N = 6, 30
mg/kg/day, 5 days) or their vehicle, saline (Sal, N = 10, 0.1 ml/day, i.p., 5
days).
SNGFR QA
nI/mm
P
mm Hg
RT
1010dyn
sec • cm
Kf
nl(sec.
mm Hg)
Sal 39 6 150 30 31 2 3.7 0.5 0.100 0.017
ACV 25 6C 80 ioa 30 2 7.2 1.7 0.054 0.009
Gan 50 6b 135 22b 23 2' 2.7 0•4b 0.240 0070b
Results are expressed as X Sn, P < 0.05
ACV vs. Sal, b Gan vs. Sal
ACV has induced ARF due to a reduction on SNGFR (single nephron
glomerular filtration rate, 63%), o Q, (glomerular plasma flow rate,
46%) and on Kf (ultrafiltration coefficient, 48%) with no changes on
(transcapillai'y hydraulic pressure gradient) and a hard elevation on RT
(total arteriolar resistence, 94%). Nevertheless, Gan treatment has not
determined renal damage, with a tendency to elevate SNGFR (28%),
keeping QA unchanged and reducing P (26%), but in this group, a mild
vasodilation and a Kf increment have also been observed. Thus, this study
suggests that only ACV presents nephrotoxicity.
Levels of urinary retinol binding protein (UKRBP) in patients with
chronic renal failure (CRF) of different etiologies. E.A.M. Menezes, MS.
Silva, S.K Nishida, S.R.S. Moreira, R. T.P. Ventura, and A.B. Pereira,
Department of Nephrology, Escola Paulista de Medicina, São Paulo, Brazil.
RBP is a low molecular weight protein (21 kD), easily filtered in glomeruli
and almost totally reabsorbed and catabolized by the proximal renal
tubules. A small quantity of this protein is eliminated in the urine under
normal conditions. We have measured URRBP levels in 89 patients aged
17 to 77 years (mean = 49.5, 61 M and 28 F). All patients had CRF and
creatinine clearances ranging from 10 to 70 mI/mm (mean = 33), and all
of them were under conservative treatment. The CRF was attributed to
chronic glomerulonephritis (13, 14.6%), chronic tubulointerstitial disease
(29, 32.6%), nephrosclerosis caused by hypertension (19, 21.3%), polycys-
tic kidney disease (14, 15.7%) and with diabetes mellitus (14, 15.7%). We
have found a significant negative correlation (r =
—0.543, P < 0.00001, N
= 89) between URRBP and creatinine clearance. Correlation was more
evident in the group of patients with chronic tubulointerstitial disease (r =
0.71). Our data suggest that URRBP can be used to evaluate the grade of
tubular damage in patients with CRF. Other studies are necessary to
determine the clinical value of this test.
Effects of nifedipine and PAF antagonist (BN 52021) in glycerol-
induced acute renal failure (GLY-ARF) in rats. E. Homsi, WE. Garcia,
E.P.O. Dias, and J.F. Figueiredo, Disciplina de Nefrologia e NMCE,
UNICAMP, Campinas, São Paulo, Brazil. Previous studies have shown a
protective action of calcium and PAF antagonists in Gly-ARF. We
evaluated renal function and sodium tubular handling in conscious rats,
treated with nifedipine 20 mg/kg p.o. or BN52021 1 mg/kg i.p., immedi-
ately after administration of 50% glycerol 5 mI/kg i.m. The functional
studies were performed 24 hours after induction of ARF, and 12 hours
after 0.06 mEq/100 g of lithium chloride p.o. Rats were placed in
metabolic cages for 2 hours, and creatinine clearance, lithium clearance,
and sodium excretion were measured. Based on these data, we determined
proximal distal tubule fractional sodium reabsorption. Rats were divided
into 4 groups: Control (N = 7), Glycerol (N = 6), Glycerol + nifedipine(N = 7), and Glycerol + BN 520221 (N = 9).
U.V. C Fr.E.Na Pr.T.Reab. D.T.Reab.
Control 52.8 5 431 128 0.23 04 78 5 99 0.4
Glycerol
Gly+nife
Gly+BN
21.7 6
44.6 12k'
38.4 7"
89 46
276 116I
188 69C
6.3 6.7a
0.9 l'
0.9 9b
41 ioa
62 lla
38
92 9
98 2l
98 1"
Abbreviations are: U.V., urinary volume (microliters/min/100 g); C,,
creatinine clearance (microliters/min/100 g); Fr.E.Na, fractional excretion
of sodium (%); Pr.T:Reab., fractional distal tubular reabsorption (%); p
<0.05 group control; "P < 0.05 group glycerol; C P < 0.05 glycerol + nife.
We concluded that in Gly-ARF there is a striking decrease in fractional
proximal tubular reabsorption of sodium, indicating a major impairment
of this nephron segment. Both nifedipine and BN 52021 attenuated the
severity of the ARF, keeping a higher glomerular filtration and urinary
volume, and a lower fractional excretion of sodium than the untreated
rats. Only nifedipine was able to preserve partially the proximal tubular
reabsorption capacity, and therefore, to protect against the proximal
tubular cell injury in this model.
Nephrotic syndrome in the third trimester of pregnancy: A report of 20
cases. S. Krasilcic, C. Luders, L.B. Saldanha, D. Penna, M. Zugaib, and E.
Sabbaga, Nephrology and Obstetrics Division, General Hospita4 University of
São Paulo, São Paulo, Brazil. Nephrotic syndrome (NS) due to pre-
eclampsia has been described since 1960. Pre-eclampsia has been accepted
as the main cause of NS in pregnancy since 1978. Besides previous
descriptions, there is only one paper with histological study from Latin
America. We report the clinical findings of 20 patients who presented NS
in the third trimester of pregnancy, followed by a percutaneal biopsy done
one week after delivery. The median age was 27 years old (20—35 years),
9 whites and 11 blacks (8 primipara, 5 on the 2nd pregnancy and 7 with 3
or more pregnancies). The presence of severe hypertension (DBP  110
mm Hg) was found in 13 women, 6 were moderate hypertensives (DBP
100—109 mm Hg) and 1 was normotensive. The median proteinuria was 7
g/24 hr (3—17 g/24 hr); serum albumin 2.3 g/dl (0.9—3.4 g/dl); total
cholesterol 331 mg/dl (80—792 mg/dl). All except one had hyperuricemia
(normal to pregnancy <4.0 ing/dI). Eighteen biopsies were representative(> 5 glomeruli). Results: 10 cases with various degrees of glomerular
endothelioses; 5 cases showing endothelioses associated with vascular
lesions due to hypertension; 3 glomerulopathies (membranoproliferative
GN, 1gM nephropathy and idiopathic focal segmental glomerulosclerosis).
Two women presented endothelioses associated with focal and segmental
sclerosis who were submitted to another biopsy in the next pregnancies,
and were evaluated without proteinuria and showed normal histology (1
case)/focal atrophy of renal parenchyma (1 case). Conclusions: 55% of the
studied patients present endothelioses, that is, pre-eclampsia as isolated
cause of nephrotic syndrome; Focal and segmental sclerosis due to
pre-eclampsia can be reversible; 28% of our patients showed histological
signs of hypertension.
Prevalence of hepatitis C antibodies in primary glomerulonephritis.
L.MV Lopes, E.P.A. Lopes, A.E.B. Silva, G.M Kirsztajn, A.B. Pereira, H.
Ajzen, M.L. G. Ferraz, and R. Sesso, Divisions of Nephrology and Gastroen-
terology, Escola Paulista de Medicina (EPM), São Paulo, Brazil. The
association between hepatitis B virus (HBV) and membranous glomer-
ulonephritis (MGN) and membranoproliferative glomerulonephritis
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(MPGN) has been described since 1971. More recently, the association
between hepatitis C virus (HCV) and glomerulonephritis (GN) has also
been reported. In this study we investigated the prevalence of HCV
antibodies (anti-HCV) in patients with primary GN followed at the
nephrology outpatient clinic. Exclusion criteria were: GN secondary to
systemic lupus erythematosus, diabetes mellitus, syphilis, malignancy,
schistosomiasis, or HBV infection. Anti-HCV antibodies were detected
using second generation ELISA assay (recombinant antigens: c22-3, c33c,
clOO-3 e 5-1-1) on stored samples drawn for the purpose of this study. Out
of 27 patients with GN, 8 had MPGN, 7 MGN, 7 focal segmental
glomerulosclerosis, 4 minimal change disease, and 1 diffuse proliferative
GN. Anti-HCV were positive in only 1 patient (3.7%) who had MPGN
and positive ciyoglobulinemia (type H IgG/IgM monoclonal and protein-
uria = 14 g/24 hr). Laboratory investigation in this patient showed
persistent elevation of serum aminotransferases (AST = 42 UI/liter and
ALT = 68 UI/liter), and after 6 months of follow-up a liver biopsy
revealed chronic active hepatitis. We concluded that the prevalence of
anti-HCV among patients with primary ON in our setting is low. This is in
accordance with the prevalence recently reported in France (0/110, 0%),
and it is lower than that observed in Japan (9/94, 8.6%).
Erythrocyte morphology in diagnosing the origin of hematuria. R.J.S.
Su,*a, P. V. Bottini, and MA. V.F.R. Alves, Renal Unit, Dept. of Medicine
and Dept. of Clinical Pathology, Faculty of Medicine, University of Campi-
nas, Campinas, São Paulo, Brazil. To evaluate the usefulness of urinary
erythrocytes, morphological examination in determining the site of hema-
tuna, a clinical prospective study was carried out, where 79 urine samples
of 58 consecutive hematuric patients were examined. Among those, 33
patients (51 samples) had glomerular disease: proliferative glomerulone-
phritis (GN) (N = 7), lupus nephritis (7), Alport's syndrome (4), IgA
nephropathy (3), idiopathic focal segmental glomerulosclerosis (3), sys-
temic vasculitides (3), Henoch-Schönlein purpura (1), hemolytic-uremic
syndrome (1), and GN with no biopsy (3). Twenty-five patients (28
samples) with non-glomerular disease were included: tubulointerstitial
disorders (N = 4), surgery or vesical catheterism (7), renal biopsy (4),
urinary tract tumors (5), urolithiasis (3), tuberculosis (1), and renal cyst
(1). Urine samples were examined by an observer unaware of the patients'
clinical features, employing phase contrast microscopy. Erythrocytes were
classified according to Hematological Classification of Bessis, and the
morphologic results were compared with the clinical and histological
diagnoses. We observed a statistical difference for stomatocytes, codocytes
and acanthocytes, and specificity, sensitivity and positive and negative
predictive value were calculated. The other morphological types were not
statistically different in urine samples with glomerular and non-glomerular
hematuria. Results were as follows:
Acanthocytes Codocytes Stomatocytes
Sensibility
Specificity
P.V.+
0.745
1.000
1.000
0.960
0.820
0.970
0.215
0.964
0.910
P.V.— 0.682 0.920 0.010
accuracy
P value
0.835
<0.001
0.911
<0.001
0.481
0.03
In conclusion, only codocytes and acanthocytes are predictors of the
glomerular origin of hematuria. In our study the presence of acanthocytes
was specific to glomerular hematuria. The absence of codocytes makes
glomerular hematuria unlike.
Microalbuminuria and physical exercise in young normal and type I
diabetic subjects. J.R.P. Tasso, J.C.B. Lucas, P.C. Oliveira, and S.R.
Ferreira Filho, Serviço de Nefrologia, Universidade Federal de Uberldndia,
Uberlândia-MG, BraziL Microalbuminuria (MCA), when present in dia-
betic patients in the early stages of the disease, represents a predictive sign
of diabetic nephropathy. In contrast, in normal individuals MCA is related
to pathological changes in coronary and peripheral vessels. On the other
hand, there are studies that relate MCA excretion to physical exercise.
The objective of the present investigation was to study young normal (N)
and type I diabetic (D) subjects submitted to a cycloergometric test and to
compare the MCA rates observed in the two groups before and after
physical exercise. Group N consisted of 14 normal volunteers aged 21.3
0.3 years (mean SEM), 12 males and 2 females, with a mean arterial
pressure of 87.4 2.1 mm Hg. Group D consisted of 8 patients with type
I diabetes mellitus aged 18.1 1.8 years, 4 males and 4 females taking
subcutaneous NPH insulin (43.7 6.7 U/day). Both groups were submit-
ted to a cycloergometric test with a progressive increase in imposed load,
and exercise was interrupted when the subject reached exhaustion. Urine
and blood samples were collected before and 3 hours after the cycloergo-
metric test. MCA was considered to be excretion of urinary albumin of
more than 20 zg/min. MCA was determined by radioimmunoassay (DPC,
Los Angeles, California, USA). The results obtained are presented in
Table 1.
Table 1. Microalbuminuria excretion [.rg/min (VR = 0.1 to 20
.tg/min)] observed before and after physical exercise in normal and type
one diabetic young subjects
Normals (N = 14)
N Patients Before After
JRPT
FSL
FMP
LFBN
JAMF
AFCD
LS
NPY
JPG
AJM
CAPC
JFMM
JN
WRN
5.7
4.6
3.1
3.4
2.3
2.3
6.2
1.3
2.6
7.2
7.7
3.1
7.7
11.0
84.8
36.7
7.3
39.0
13.5
4.8
77.2
33.6
33.0
22.5
12.5
3.7
9.8
7.0
Mean
SEM
4.9
0.7
27.5a
6.9
Diabetics (N = 8)
D Patients Before After
JCBL
ECS
SMS
WRO
MAO
DDS
RAM
NAP
6.5
0.7
9.2
9.7
6.8
5.4
5.7
5.0
5.6
17.0
143.3
5.2
6.3
4.0
30.0
4.0
Mean
SEM
6.1
1.0
26.9a
17.0
ap < 0.05; Tcal. = 3.25; Tcrit.
exercise; Not significant.
= 1.77; (MCA)N X (MCA)D After
The present data show that the two groups, type I diabetic and normal
young subjects, behaved similarly in terms of the presence of MCA before
and after physical exercise.
Serum levels of retinol binding protein (RBP) in patients 4th chronic
renal failure (CRF). MS. Silva, E.A.M Menezes, S.K Nishida, S.A. Draibe,
H Ajzen, and A.B. Pereira, Department of Nephrology, Escola Paulista de
Medicina, São Paulo, Brazil. Plasma levels of low molecular weight
proteins are increased in CRF. In the present study, serum RBP was
quantified to evaluate which fraction would be increased, free RBP (21
kD), prealbumin-bound RBP complex (PA-RBP, 85 kD), or both. We
studied 53 CRF patients who had a good nutritional status and were
without heavy proteinuria; serum creatinine (Cr) ranged from 1.7 to 9.8
mg/dl (mean 3.6 mg/dl). A control group had 31 healthy subjects (Cr range
0.7—1.2 mg/dl). RBP concentration in serum was determined by an EIA.
Some samples were submitted to gel filtration (Sephacryl S-200) to
estimate free RBP and PA-RBP. Prealbumin (PA) was determined by
radial immunodiffusion. In CRF patients total RBP (79.8 35.6 mg/liter),
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free RBP (32.3 15.5 mg/liter, N 14) and PA-RBP (70.0 35.4
mg/liter, N = 14) levels were all significantly elevated when compared to
the control group (total RBP = 33.5 8.7 mg/liter, free RBP = 4.5 2.5
mg/liter, N = 10 and PA-RBP = 30.7 6.8 mg/liter, N = 10). There was
a positive significant correlation between total RBP (y) with Cr (x): y
35.2 + 12.7x (r = 0.729), free RBP (y) with Cr (x): y = 4.1 + 5.7x (N =
17, r = 0.818) and PA-RBP (y) with Cr (x): y = 27.1 + 9.5x (N = 17, r =
0.506). Total RBP concentration (y) was also significantly correlated with
PA (x): y = 0.26x — 4.2 (r = 0.646), as well as PA-RBP (y) with PA (x):
y = 0.30x — 44.8 (N = 17, r 0.774); however, no correlation was found
between free RBP and PA. Our data indicate that the increase in total
serum RBP in CRF patients is associated with the retention of free RBP
due to reduced GFR. High levels of PA-RBP could be related to
additional ligation between free RBP (free RBP + retinol) and PA.
Alternatively, these data can be explained by a greater synthesis and
hepatocytic liberation of the PA-RBP complex.
Urinary levels of retinol-binding protein (urRBP) in glomerulopathies.
G.M. Kirsztajn, S.K Nishida, M.S. Silva, L.M.V. Lopes, M.CA Monteiro,
M.H. Vaisbich, H. Ajzen, andA.B. Pereira, Escola Paulista de Medicina, São
Paulo, Brazil. urRBP, a marker of proximal tubular function, was deter-
mined by enzymeimmunoassay in isolated urine samples of 132 patients
with glomerulopathies: 15 with minimal change disease (MCD), 44 with
focal segmental glomerulosclerosis (FSOS), 30 with membranous gb-
merulopathy (MGN), 15 with membranoproliferative glomerulonephritis(MPGN), and 28 with post-infectious GN. urRBP levels were normal
(< 0.4 mg/liter) in all patients with post-infectious ON and 12/15 with
MCD; in this group, the 3 patients with levels above 0.4 mg/liter, in a
period of 4 months or less had these levels normalized, in coincidence with
response to treatment. Out of 44 patients with FSGS, 32 had nephrotic
syndrome (NS), 9 had non-nephrotic proteinuria, and 3 were without
proteinuria when evaluated. The patients with FSGS had the more
elevated levels of urRBP among all the GN, and the reduction of these
levels was usual if a remission of the nephrotic syndrome occurred. In the
patients with FSGS and NS, normal levels of urRBP were markers of a
good response to treatment. In the patients with MGN and MPGN with
NS, urRBP was not a good predictor of response to treatment, but
chronically elevated levels seemed to be convenient markers of a poor
outcome of renal function. Tubular and interstitial status seems to
interfere in the prognosis of renal disease. In MCD and FSGS, low levels
of urRBP showed a clear association with good responses to treatment;
such an association has not been demonstrated, so far, for MON and
MPGN.
Renal involvement in children and women with urinary tract infections.
M.R. Teodósio, E. Oliveira, M. T. Antunes, and C. C. de Freitas, Departa-
mento de Medicina ClInica, Universidade Federal de Pemambuco, Recife,
Brazil. We employed a dip-slide method (UROTUBE-ROCHE) to diag-
nose urinary tract infections (UT!) in 880 children (aged from 1 to 10
years) and 125 women (mean age 30 years), living in low-income commu-
nities of Grande Recife. To study the renal involvement we used ELISA
to determine the urinary retinol binding protein (RBP). In addition, the
maximum urinary concentrating test was performed. Sixty-six children and
32 women with UT! underwent ultrasound studies and 99 TC-DMSA
renal scan. Most of the children (56%) and women (50%) had asymptom-
atic bacteriuria. Unilateral renal scarring was detected in 17 children
(27%) and in 9 women (27%). There was good correlation between the
detection of a scarred kidney and the lower renal concentrating ability (P
< 0.0001). The urinary RBP was significantly increased in UT! groups
compared to control groups independently from the nutritional status (P
< 0.00003). These results illustrate significant evidence of renal involve-
ment in a population at risk to progress in UT! complications, and point
out the importance of bacteriuria screening programs in our communities.
Renal evaluation of patients with bancroftian filariasis treated with
diethylcarbamazine (DEC). M.E. Pinheiro, F.A. T Fireman, A.P. Madeiro,
M. Serapiao, and N. Schor, UFAL, Maceió (AL) and EPM, São Paulo,
Brazil. To determine renal abnormalities during treatment with DEC (6
mg/kg/day, single oral dose/12 days), 19 asymptomatic microfilaremic
individuals were selected randomly, 4 (21%) females and 15 (79%) males
with an average age of 19.5 1.6 (X SE) years. All individuals were
evaluated in the laboratory and clinically before treatment (BT), on the
5th and 11th days of DEC during internment. They were also evaluated at
1, 3, and 6 months after treatment. The laboratory evaluations carried out
were: urinalysis, 24 hour proteinuria, microfilaremia and microfilaruria
determination, serum creatinine (Sr) and creatinine clearance (Ccr). A
control group of 5 individuals (27.5 3.4 years old) was submitted to the
same laboratory examinations before, during, and after the treatment with
DEC. All patients were asymptomatic BT. The mean microfilaremia BT
was 12 2,4 mf/20 1.d, remaining positive in 5 (26.5%) patients after 3
months and in 1 (5.3%) after 6 months. The renal function was normal in
100% of the patients, with Sr 0.92 0.02 mg/dl and Cr 90.3 6.8
mI/mm. Transitory hematuria was observed in 1 patient during treatment.
The mean proteinuria was 284 43 mg/24 hr BT and 353 76.5 mg/24
hr on the 5th day. The mean proteinuria was 305 54 mg/24 hr in the 1st
month control and 130 18.2 mg/24 hr in the 6th months of evaluation
(16 patients). Retinol binding protein (RBP) was determined in 4
individuals with increased proteinuria, with normal results. The control
group showed normal renal function and proteinuria in normal levels (70.4
18.1 mg/dl) in all cases. These preliminary data suggest that the
proteinuria found is probably of glomerular origin and caused by filarial
infection, since a decreasing proteinuria level was observed after treat-
ment.
Concordant and discordant xenotransplantation models using experi-
mental heart transplantation. V. Bueno, L.A. Moura, A. Pacheco Silva, and
J.O.P. Medina, Disc. Nefrologia/Anatomia Patológica, EPM, São Paulo,
Brazil. The relative shortage of organs from human donors for transplan-
tation has stimulated a renewed interest in using animal organs. Long-
term survival of xenografts has not been achieved, despite all the available
immunosuppressive protocols. Organs transplanted between discordant
species (Xd) are rejected within minutes or hours after revascularization,
while concordant xenografts (Xc) are rejected over a period of days. To
investigate these issues, concordant and discordant heterotopic cardiac
xenograft models were performed using a modified microvascular tech-
nique described by Ono and Lindsey. Rejection was monitored by external
palpation. In Xc, using hamsters as donors and Wistar rats as receptors (N
= 6), hearts were totally rejected at 4 days, while in Xd, using guinea pigs
as donors and Wistar rats as receptors (N = 6), hearts were rejected
between 11 and 83 minutes. Light microscopy analysis of the Xc showed
myocyte necrosis, thrombosis of small blood vessels and extensive inter-
stitial cellular infiltration, with mononuclear and polymorphonuclear cells
and hemorrhage. Immunofluorescence studies showed absence of immu-
noglobulins or complement deposition. The histologic picture in the Xd
grafts was composed by fibrin thrombi in the small blood vessels, with
margination of polymorphonuclear cells, and slight interstitial edema.
Direct immunofluorescence showed rat Ig linear deposition in blood
vessels and myocyte membranes. We concluded that in Xd the immune
response was a type of hyperacute humoral rejection, probably mediated
by a pre-formed antibody resulting in a non-functioning heart within a few
minutes after revascularization, whereas in Xc there was predominantly
cell-mediated acute rejection with histologic evidence also compatible
with humoral phenomena.
The results of 117 renal transplantations in the first year of the
systematic program in a non-university hospital. AM. Santana, Jr., C.S.
Melaragno, H.T Silva, Jr., J.C. Batista, P.S. Lucone, and J.O.M. Pestana,
Hospital Dom Silvério, São Paulo, Brazil. The analyzed service keeps 130
patients in their dialysis program: 76% on hemodialysis, 19% on CAPD,
and 5% on IPD, The renal transplantation program began in June/1992.
Since then, 117 kidney transplants were performed: 83 (72%) with
cadaveric donors and 33 (28%) with living donors. Kidneys were trans-
planted in 34 (26%) recipients from the service and in 83 (74%) patients
from other units. The organs were harvested from the Organ Procurement
Organization at Escola Paulista de Medicina or from São Paulo's Health
Secretary. The histocompatibility tests were performed in the laboratory
for transplantation immunology at the Escola Paulista de Medicina. The
immunosuppression protocol applied was triple therapy (AZA + PRED
+ CSA). The mean follow-up time was 10 months with a mean of 18
out-patient appointments per patient. The 1 year patient actuarial survival
rate was 87% for cadaveric donors and 100% for living donors. The 1 year
graft actuarial survival rate was 81% for cadaveric donors and 90% for
living donors. The incidence of acute tubular necrosis was 26% in the
cadaveric organ recipients. The mean hospitalization time was 17 (7—61)
days for cadaveric recipients and 18 (8—36) days for living donors
recipients. The mean hospitalization time for living donors was 6 days.
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There were 21 readmissions, 9 of them due to renal dysfunction (7 acute
rejections and 2 cyclosporine nephrotoxicities), 3 due to surgical compli-
cations, 1 due to diabetic decompensation, and 8 due to infection. The
mean readmission permanence was 16 (2—38) days. Causes of death and
graft loss are shown below. We have proven the viability and effectiveness
of a renal transplantation program in a non-university hospital where 117
transplants were performed in 1 year. Nevertheless, viability requires the
support of a universitary organ procurement organization and a histocom-
patibility test laboratory.
Cause Deaths Cause Losses
cardiovascular 02 death with functioning graft 07
infections 04 cellular acute rejection 03
indeterminate 03 humoral acute rejection
technical loss
03
03
Total 09 14
The consequences of compulsory withdrawal of cyclosporine in kidney
transplants. A.B.L. Barra, J. C. Sampaio, F. Ruzany, and S.F.F. Santos,
Nephrology Division, Rio de Janeiro State University, Rio de Janeiro, Brazil.
The interruption of cyclosporine (CsA) supply by the Rio de Janeiro State
government, obliged 37 patients to withdraw from CsA treatment 2
months to 3 years (ii = 1.2 0.9 years) post-transplant. The patients
followed a conversion protocol based on a temporary increase of pred-
nisone and a permanent increase of azathioprine dose. Seventeen trans-
plant patients continued CsA treatment for various reasons. There were
no significant differences between the two groups concerning age, sex,
donor compatibility, CsA dose, or previous acute rejection episodes.
Blacks were predominant among converted patients (23) and non-blacks
were predominant among the non-converted patients (11). Six converted
patients had chronic rejection and 2 had focal and segmental sclerosis
recurrence. Two non-converted patients had chronic rejection. In 1 year,
7 converted patients had acute rejection episodes, 6 lost their grafts due to
immunological causes, 1 lost the graft due to arterial thrombosis, and 2
died of infectious causes. Among non-converted patients there were no
acute rejection episodes or development of chronic rejection. One patient
with previous chronic rejection lost the graft. These data demonstrate the
necessity of CsA as an immunosuppressive agent in kidney transplants
during follow-up and, in Brazil, of its provision by the government health
care system.
Evaluation of kidney donors 3 to 12 years after nephrectomy. S.A.
Bobbio, E.J. Tonato, and J.O.M. Pestana, Nephrology, Escola Paulista de
Medicina, São Paulo, Brazil. All of the 295 donors for kidney transplants
performed between 1981 (12 years follow-up) and 1990 (3 years follow-up)
were summoned for evaluation. Seventy-six (76) showed up for the visit.
The evaluation consisted of a clinical examination and laboratory tests:
serum creatinine, sodium and potassium and urinary sediment. Of these
76 donors, 12 (16%) showed 1 or more alterations related directly or
indirectly to kidney function. Six patients (8%) had a serum creatinine 
1.5 mg/dl, and higher than the pre-transplant levels. Two patients (3%)
had hematuria (1 patient during nephrotic cramps, and another as an
isolated finding, with 15 r.b.c. per field, + of erythrocytic dismorphism).
Two patients (3%) had nephrotic cramps. Four patients (5%) had a
history of 1 or more episodes of urinary tract infection after transplanta-
tion, of which 3 had cystytis and 1 had pyelonephritis. Of these 4 patients,
2 presented also with a decrease in renal function evidenced by a rise in
serum creatinine (1.1 to 1.7 and 1.1 to 1.5 mg/dl). Hypertension was found
in 4 patients (5%), but only 1 developed loss of renal function with serum
creatinine increasing from 1.3 to 1.9 mg/dl and creatinine clearance
decreasing from 72 mI/mm before nephrectomy to 57 mI/mm 3 years and
9 months after. Patients with mild hypertension (levels of up to 140 X 90
mm Hg) prior to nephrectomy were not considered in this study. We
conclude that although 16% of kidney donors developed some kind of
alteration after nephrectomy, there was no significant prejudice of renal
function.
The role of experimental chronic aluminum intoxication in natural cell
cytotoxicity. C. Tzanno-Martins, L.S. Azevedo, A.F. Carvaiho, V. Jo,getti, E.
Sabbaga, M Marcondes, and A.J.S. Duarte, Immunology and Nephrology
Divisions, University of São Paulo Medical School, São Paulo, Brazil.
Morbidity and infections are higher in aluminum intoxicated patients with
chronic renal failure. The aim of this study was to evaluate the effect of
aluminum intoxication on natural cytotoxicity activity in Lewis rats with
normal renal function (NRF) and chronic renal failure (CRF) intoxicated
and non-intoxicated by aluminum (Al). The animals were divided into 4
groups: NRF, NRF + Al, CRF, CRF + Al. The subtotal nephrectomy
model was used to obtain experimental uremia. A 0.25 M MCI3 solution
was injected into the peritoneal cavity until 30 mg of Al/rat was achieved.
Cytotoxicity assay was done using spleen cells of Lewis rats (effector cells)
in serial dilution from the initial concentration of 10 X 106 cells/mI and
YAC1 cells (target cells) in the concentration of 1 x 106 cells/mI. Target
cells were treated previously with 51Cr. Both effector (E) and target (T)
cells were cultured during 4 hours in 3 E:T ratios. After this period 51Cr
release from lysed target cells was measured in a 1257 (LKB) gamma
counter.
Group N 50:1(%) 25:1(%) 12.5:1(%)
NRF 8 11.17 1.87 6.19 0.96 3.83 0.64
NRF + Al 8 4.28 1.31 2.47 Ø•3Ø 1.02 0.39a
CRF 9 5.08 0.62a 3.64 0.7P 2.79 0.70
CRF + Al 7 4.85 1.08a 1.37 0.62a 1.19 0.78a
a p < 0.05
We verified a significant decrease in natural cytotoxicity in cells from CRF
and intoxicated animals in all E:T ratios analyzed. This would be an
explanation of the higher incidence of tumors and viral infections in CRF
patients.
Retrospective study of 2 patterns of aluminum-related bone disease in
hemodialyzed patients. A.B. Carvaiho, R.R.S. Lobño, V.P. Marques, H.
Ajzen, and S.A. Draibe, Department of Nephrology, Escola Paulista de
Medicina, São Paulo, Brazil. Osteomalacia (OM) and adynamic bone
disease (ABD), 2 distinct histological patterns of low bone turnover, have
been identified in patients with aluminum bone deposits. The physio-
pathologic process of these 2 forms of bone disease is poorly understood.
In this study, we compare the biochemical profile of both histological
patterns of 13 patients on chronic hemodialysis selected on the basis of
aluminum-related bone disease revealed by bone biopsy. The following
parameters were analyzed: age (years), time on dialysis (i'D; years),
aluminum deposits on trabecular surface (AIS; %), total calcium (TCa;
mg%), phosphorus (P; mg%), alkaline phosphatase (AP; lU/liter), and
amino-terminal parathormone (N-Pth). OM was present in 7 patients
(54%), whereas ABD was diagnosed in 6 (46%). All of ABD and 57% of
OM patients have received oral calcitriol (0.25 sg; NS). The following
results were observed:
N Age TD MS TCa
OM 7 41.5 15 6.1 1.9 78.5 6.9 9.4 2.2
ABD 6 48.3 9.8 5.6 4.3 51.6 19.4 9.6 1
P NS NS <0.01 NS
N P AP N-Pth
OM 7 5.4 2.6 149 61.7 10.8 8.5
ABD 6 5.7 2 153 72 10.3 5.2
P NS NS NS
Conclusions: (1) The less percentage of bone aluminum staining in ABD
suggests a minor role of the aluminum deposits in its pathogenesis; (2)
calcitriol therapy could also be implicated in the pathogenesis of ABD.
Oral calcitriol pulse therapy in hemodialyzed patients with secondary
hyperparathyroidism (HP). R.R.S. Lobão, A.B. Carvalho, J.G.H. Vieira,
H.M. Sanders, H. Ajzen, and S.A. Draibe, Department of Nephrology, Escola
Paulista de Medicina, São Paulo, BraziL Oral calcitriol, three times a week
(pulse therapy), is effective in many patients with moderate to severe
secondary hyperparathyroidism. The present study was comprised of 8
patients on chronic hemodialysis with HP (7 females, 1 male; mean age
sn = 42.6 14.8 years; time on dialysis = 6.0 3.2 years). Total calcium,
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phosphorus, alkaline phosphatase, amino-terminal parathormone (N-
PTH), hemoglobin, and body mass index (BMI) were measured in 2
distinct phases, 1 before and 5,7 2.7 months after pulse therapy. Initial
and final doses were 2.25 and 3.9 1.1 pg/week, respectively. Calcium
carbonate was administered to all patients as a calcium supplement and/or
phosphate binder. Statistical analysis revealed a significant decrease of
N-PTH (139.1 32.4 to 69.6 27.5 pmol/liter; P < 0.01) and an increase
of total calcium (9.1 1.4 to 10.5 0.7 mg/dl; P < 0.01). No significant
differences were observed among the other parameters. Only 1 patient
developed hypercalcemia, in whom the calcium supplement was discon-
tinued. No patients presented hyperphosphatemia. Conclusions: (1) oral
calcitriol pulse therapy was effective on the management of HP; (2)
hypercalcemia and hyperphosphatemia were infrequent.
Chemical parathyroidectomy with intravenous calcitriol in hemodialy-
sis patients. R.MA. Moysés, R. C'. Pereira, L.M Reis, MM. Machado, E.
Sabbaga, and V. Jorgetti, Nephrology Departament, FMUSP, São Paulo,
BraziL Secondary hyperparathyroidism (HP) is one of the most frequent
complications observed in uremic patients. The traditional treatment,
cirurgic parathyroidectomy (PTX), poses potential risks and complica-
tions. Oral calcitriol, in doses from 0.25 to 0.5 ,sg daily, only provided
control. Recently, some authors have described a direct suppressor effect
of calcitriol over parathyroid gland, when this vitamin is used in high
doses. The aim of our study was to compare this action of high doses of
calcitriol and observe the occurrence of side effects. We selected 7 patients
under hemodialysis treatment with the diagnosis of hyperparathyroidism,
using clinical and laboratory parameters and bone biopsy. This group was
composed of 6 women and 1 man, with a mean age of 36.4 years. We
started with a beginning dose of 3 sg, and raised it slowly to 18 sg per
week. The results are in this table:
Week
1 4 7 10
Calcium mg/dl 8.42 9.2 9.53 9.33
Phosphorus mg/dl 7.13 5.47 6.13 6.1
Alkaline phosphatase 10.71 11.4 9.81 9.28
Semanal dose 0 8.33 16 18
Cumulative dose 0 17.83 53.3 105.3
Ca x P product 60.56 50.32 53.33 56.91
Parathormone 24.2 11
(The values of intact parathormone and alkaline phosphatase are
expressed as augmentation of the normal value)
No one patient had any symptoms or signs that obligated the discontinu-
ation of this therapy. In conclusion, intravenous calcitriol is effective and
without great risks (when we follow serum levels of calcium and phospho-
rus) in the treatment of secondary HP.
Oral pulse calcitriol in the treatment of secondary hyperparathyroid-
ism. MF. Bandeira, E. Camargo, KR. Ban-os, C. Takahashi, and F. Ruzany,
Clinica Doença Rnais RL Fundação Rim Fancisco Santino Filho RJ and
Laboratório Nobel RS, Rio de Janeiro and Porto Alegre, BraziL Secondary
hyperparathyroidism (2°HPT) develops in almost all patients with chronic
renal failure, especially those with prolonged survival. Recent reports
suggest that abnormalities in Vitamin D metabolism are responsible for
the pathogenesis of bone disease in uremic patients, and that parenteral
calcitriol, in high doses, has been shown to be effective in the treatment of
2°HPT. In the present study we analyzed the effect of oral intermittent
calcitriol in the treatment of 2°HPT. Nine patients (5 men and 4 women)
aged 16—78 years old (mean 38.5 years) undergoing regular HD were
studied. They received 1—1.5 tg oral calcitriol post-hemodialysis session,
3x/week. Determinations of serum parathyroid hormone using inmsuno-
chemiluminometric assay for intact hormone (PTHi) were available
before and after the oral calcitriol treatment. All patients had previously
been treated with daily doses of oral calcitriol (0.25—0.5 ig/day) and
calcium carbonate or acetate as the P04 binding agents. Mean PTHi levels
before oral "pulse" were: 1048 pg/mI (range 296—2000 pg/mI, normal
values 10—55 pg/mI). Twelve weeks after treatment mean PTHi was 478
pg/mI (range 113—817 pg/mI, P C 0.05) and 24 weeks after was 377 (range
26—1357 pg/mI P C 0.05). Serum PTHi levels decreased over time and
normal values could be observed in 3/7 patients in 24 weeks. Hypercalcc-
mia was not observed during this study. We conclude that calcitriol oral
pulse therapy is safe and effective reducing the levels of PTHi in HD
patients with 2°HPT.
Large-conductance ionic channel in glomerular mesangial cells (MC).
A.C. Cassola, Si. Hadad, and N. Schor, Instituto Ciências BiolOgicas USP,
Nephrology Division, Escola Paulista de Medicina, São Paulo, BraziL
Glomcrular MC are myofibroblasts that contract in response to several
hormones, including vasopressin and angiotensin II. It is generally ac-
cepted that the tonus of these cells controls the filtration surface and,
hence, the glomerular filtration coefficient. Upon hormonal stimulation
the cell membrane depolarizes, mostly through an increase in C1
conductance. This depolarization activates L-type Ca + channels. Ca +
entry contributes to the free-ion intracellular pool that triggers the
contraction. So far, at the single channel level K cation and a conduc-
tance (4 PS) Cl channel have been described in the plasma membrane of
MC. Employing the patch clamp technique, we have observed a large
conductance channel, with some selectivity to C1, in the plasma mem-
brane of cultured MC. The channel is expressed in both cell-attached and
cell-free patches. Its conductance in symetrical, 140 mM C1 solutions
amounts to 400 p5. Its selectivity favors C1, but also allows the flow of
monovalent cations, like Na and Kt Interestingly, it is more selective to
Na than to Kt Barium, in the extracellular solution, abolishes the
discrimination between the 2 ions, without affecting the channel conduc-
tance in Ct solutions. The channel displays a complex potential gating:
depolarization quickly inactivates open channels and hyperpolarization
activates transiently closed channels. This channel population certainly
contributes to the membrane conductances related to potential changes,
induced by hormones, in the plasma membrane of MC.
Nitric oxide (NO) can be a mediator of renal response to erythropoie-
tin-induced polycythemia.A.D.O. Paixão, C. V. Razvickas, LA. Draibe, and
N. Schor, Nephrology Division, Escola Paulista de Medicina, São Paulo,
BraziL Chronic administration of erythropoietin (EPO) on intact rats
induces an increase in hematocrit (Hct) and vasodilation on renal
microcirculation without alteration of global renal function. Among the
mediators implicated are vasodilatoly prostaglandins (POs) and NO. In
this study, L-NAME (N°-nitro-L-argininc methyl esther), in a dose of 2
mg/kg i.v., in bolus, was administered to animals previously treated with
EPO (300 U/kg, s.c., 2x/week, during 2 weeks). Global renal function and
single nephron (SN) GFR were analyzed before and after L-NAME.
Hct
%
TRVR
mm Hg ml mm
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%
SNGFR
nI/mm
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L-NAME
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8
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28
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X su. C 0.05 : a vs. Control, 1,vs. EPO.
L-NAME elicited reduction on GFR and SNGFR by decreasing RPF, due
to an increment in TRVR (total renal vascular resistance). The elevation
in TRVR in association with an increase in FE suggests an important
post-glomerular vasoconstriction. NO, as well as PGs, might be a mediator
of the vasodilation when Hct is high in response to EPO.
Glycosaminoglycan synthesized by mesangial cells from diabetic rats.
Si. Hadad, Y.M Michelacci, and N. Schor, Nephrology and Cellular Biology
Division, Escola Paulista de Medicina, São Paulo, BraziL The mesangial
cells (MC) secrete the components of the mesangial matrix, including
glycosaminoglycan (355-GAG). Diabetic nephropathy is characterized by
mesangial matrix increase, which leads to glomerular sclerosis. The
objective of the present work was to characterize the 35S-GAG synthesized
in vitro by MC from diabetic rats (DR). Diabetes was induced by
streptozotocin and the MC were obtained by sieve technique after 4
months of induction. The 355-GAG were identified by a combination of
agarose gel electrophoresis and enzymatic degradation with specific
mucopolysaccharidases. The results have shown that MC synthesize
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dermatan sulfate (DS) and heparan sulfate (HS). Most of the DS is
secreted to the culture medium (80%), while the HS remains in the cell
fraction (70%). The cells from DR synthesize and secrete 2 times more
35S-GAG than their normal counterparts and the DS sulphation degree is
higher. These results suggest that the GAG could be involved in the
process of diabetic glomerular sclerosis.
Nephrotoxicity of Bence Jones proteins: Interference in renal epithelial
cell acidification. A.L. Nicastri, M.J.B.A. Prado, A. Sesso, M. On, M
Marcondes, and E.B.A. Prado, Laboratório de Fisiopatologia Renal, HC,
FMUSP, São Paulo, Brazil. Physicochemical characteristics of Bence Jones
(BJ) proteins may interfere in nephrotoxicity. We studied renal epithelial
cell endosome-lysosome system acidification after incorporation of 2
human lambda isotype BJ proteins (AK: p1 7.4 and GL: p1 4.9, both with
molecular wt —30 kD) in whole animals and in cell culture. Rats were
infused with a single dose of each protein, alone or associated to DAMP,
and renal biopsies were obtained after 30 minutes for high resolution
quantitative immunocytochemistry, by immunogold labeling. Endosome-
lysosomal structures were analyzed according to density of labeling for
DAMP (protein-A gold particles per unit of area, pA-gold/sm2); pH was
estimated by using the ORCI method, based on DAMP distribution.
Results were expressed as median (25—75 percentiles) and compared by
Mann-Whitney test (adopting 0.05 as significance level). In A6 renal
epithelial cell cultures, pH was analyzed qualitatively by acridine orange
fluorescence after BJ protein incorporation in the same conditions.
Results: DAMP labeling (p1 7.4 vs. 4.9): 3.3 (0—7.5) versus 9.5 (0—27.0), P
<0.05. Estimation of pH revealed 6.8 (6.4—7.0) versus 6.3 (5.8—7.0), P <
0.001. By acridine orange fluorescence, acidic compartiments were dis-
persed in cytoplasma (p1 7.4), with perinuclear acidic structures when cells
were incubated with BJ protein p1 4.9. Conclusion: We concluded that less
anionic BJ protein led to impaired lysosomal acidification, fundamental
for adequate protein processing and catabolism.
Contrasting results and interpretation of dipyridamole-thallium tests
(DTF) in patients on CAPD versus hemodialysis (HD). M.E. Canziani, M
Cendoroglo, M. Durão, R. Lobão, J.L. Cassiolato, H. Ajzen, and S. Draibe,
Nephrology Division, Escola Paulista de Medicina, São Paulo, Brazil. We
recently reported an increased occurrence of left ventricular hypertrophy
(LVH) and altered myocardial perfusion associated with severe ventricu-
lar arrhythmias (VA) in HD patients. Such an observation has not been
tested in CAPD. We thus compared the prevalence of LVH (by echocar-
diography), VA (by 24 hours EKG monitoring), and alteration in myo-
cardial perfusion (by DTI'), in CAPD (N = 57, 22F 35M, mean age 44.9
2.2 years) (X SE) and HD patients (N = 81, 40F 41M, mean age 42.8
1.6 years). Coronary angiography (CAG) was performed as indicated by
clinical status or DiT alterations. Mean duration of dialysis programs was
14.7 1.9 versus 28.2 3.2 months, respectively (P < 0.01). The
prevalence of hypertension was significantly lower in CAPD than in HD
(44% vs. 68%, P < 0.01). LVH was present in 68% of CAPD and in 94%
of HD (P < 0.001). Severe cardiac arrhythmias (Lown 3—4) occurred in
7% of CAPD and in 23% of HD (P < 0.01). Altered DT was present in
20% of the tested patients on CAPD and in 19% of HD (NS). Significant
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coronary lesions were revealed by CAG in 80% of CAPD and in only 25%
of the HD group. These data show that patients on CAPD have a lower
prevalence of hypertension, LVH and severe ventricular arrhythmias
compared to HD. On the other hand, DIT is significantly more specific
for detection of coronary obstructions in CAPD than in HD patients.
Although we cannot exclude a bias in selecting patients for the HD and
CAPD programs, factors inherent to each form of treatment might be
involved in the expression of the two different ischemic diseases: athero-
sclerotic (organic) in CAPD and non-atherosclerotic (functional) in HD.
Recombinant human erythropoietin (rHuEPO) in chronic renal pa-
tients on hemodialysis: Factors that predict the response. M Amar, M
Cendomglo Neto, M.A,J. Nadaletto, C. Stabile Neto, H. Ajzen, and S.A.
Draibe, Disciplina de Nefrologia, Escola Paulista de Medicina, São Paulo,
BraziL Recombinant human eiythropoietin has proven to be an effective
drug in the correction of anemia in chronic renal patients on hemodialysis,
the high cost of treatment being the major limiting factor for its use in
Brazil. In order to identify predictive factors in terms of the response to
the drug for a rational use of treatment, a study was conducted in 46 renal
patients enrolled in a regular dialysis program. Twenty-eight were females
and 18 were males; mean age was 38.7 12.8 years, mean duration of
renal disease was 7.8 5.5 years, and mean duration of dialysis 3.8 3.3
years. Previous mean amount of blood transfused was 8.2 9.0 U of red
cells per patient. For the study, the patients were divided into 3 groups: (1)
22 patients receiving EPREX (CILAG) by the intravenous route; (2) 12
patients receiving HEMAX (BIOSSINTETICA) first by the intravenous
and then by the subcutaneous route; (3) 12 patients receiving RECOR-
MON (BOEHRINGER) by the subcutaneous route. The objective was to
reach a hematocrit (hct) of 30% and to keep it stable at 30—35%, and the
necessary dose adjustments were made to achieve this result. All patients
were submitted to rigorous clinical follow-up, to hematologic and bio-
chemical tests and to the control of iron metabolism parameters through-
out the study period. Thirty-nine of the 46 patients who started the
protocol reached the target hct of 30%. The correlations between the dose
of rHuEPO needed to reach this hct value (dose 1) and initial hematocrit,
reticulocytes, ferritin, transferrin saturation and urea were calculated.
Dose 1 was also tested for correlation with time of renal disease, time on
dialysis, total number of transfusions, and patients who were carriers of
hepatitis B. The same tests were performed with the dose of medication
employed to maintain hct between 30 and 35% (dose 2). The only
statistically significant correlation was between dose 1 and dose 2 (P <
0.000001, r = 0.8261). The fact that patients with high iron stores (ferritin
> 400 ng/ml) might respond to lower rHuEPO doses motivated the
division of the 39 patients into 2 different study groups. The group with
high iron stores consisted of 13 patients presenting mean ferritin of 1021.7
721.5 ng/ml, dose 1 of 63.1 26.5 U/kg per dialysis, and dose 2 of 42.3
30.9 U/kg dialysis. The group with ferritin < 400 ng/ml comprised 26
patients presenting mean ferritin of 144.7 128.0 ng/ml, dose 1 of 56.0
15.5, and dose 2 of 49.0 19.4. The two groups did not differ in terms of
response evaluated by statistical analysis of doses 1 and 2. We conclude
that other factors not detected in the present study determine the
response to rHuEPO.
